BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1170715	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m1/s1	FDLRDRBESBJAAV-CYBMUJFWSA-N	555025	(2R)—N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 1	5-hydroxytryptamine receptor 2A	Human	 2.00								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555025&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540522	471695782							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170716	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m1/s1	FDLRDRBESBJAAV-CYBMUJFWSA-N	555025	(2R)—N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 1	5-hydroxytryptamine receptor 7	Homo sapiens	 2.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555025&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540522	471695782							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170717	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m1/s1	FDLRDRBESBJAAV-CYBMUJFWSA-N	555025	(2R)—N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 1	D(2) dopamine receptor	Homo sapiens	 226								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555025&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540522	471695782							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170718	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)CCO	InChI=1S/C19H27FN4O2/c1-2-23(19(26)7-12-25)11-10-22-8-5-17(6-9-22)24-18-4-3-16(20)13-15(18)14-21-24/h3-4,13-14,17,25H,2,5-12H2,1H3	YPTQUGODRIZPOA-UHFFFAOYSA-N	555026	N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-3-hydroxypropanamide::US11339151, Example 2	5-hydroxytryptamine receptor 2A	Human	 2.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555026&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540526	471695783							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170719	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)CCO	InChI=1S/C19H27FN4O2/c1-2-23(19(26)7-12-25)11-10-22-8-5-17(6-9-22)24-18-4-3-16(20)13-15(18)14-21-24/h3-4,13-14,17,25H,2,5-12H2,1H3	YPTQUGODRIZPOA-UHFFFAOYSA-N	555026	N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-3-hydroxypropanamide::US11339151, Example 2	5-hydroxytryptamine receptor 7	Homo sapiens	 9.30								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555026&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540526	471695783							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170720	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)CCO	InChI=1S/C19H27FN4O2/c1-2-23(19(26)7-12-25)11-10-22-8-5-17(6-9-22)24-18-4-3-16(20)13-15(18)14-21-24/h3-4,13-14,17,25H,2,5-12H2,1H3	YPTQUGODRIZPOA-UHFFFAOYSA-N	555026	N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-3-hydroxypropanamide::US11339151, Example 2	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555026&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540526	471695783							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170721	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C19H27FN4O2/c1-3-23(19(26)14(2)25)11-10-22-8-6-17(7-9-22)24-18-5-4-16(20)12-15(18)13-21-24/h4-5,12-14,17,25H,3,6-11H2,1-2H3/t14-/m1/s1	HJURXLMWJCKIJE-CQSZACIVSA-N	555027	(2R)—N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 3	5-hydroxytryptamine receptor 2A	Human	 4.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555027&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540503	471695784							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170722	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C19H27FN4O2/c1-3-23(19(26)14(2)25)11-10-22-8-6-17(7-9-22)24-18-5-4-16(20)12-15(18)13-21-24/h4-5,12-14,17,25H,3,6-11H2,1-2H3/t14-/m1/s1	HJURXLMWJCKIJE-CQSZACIVSA-N	555027	(2R)—N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 3	5-hydroxytryptamine receptor 7	Homo sapiens	 5.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555027&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540503	471695784							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170723	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C19H27FN4O2/c1-3-23(19(26)14(2)25)11-10-22-8-6-17(7-9-22)24-18-5-4-16(20)12-15(18)13-21-24/h4-5,12-14,17,25H,3,6-11H2,1-2H3/t14-/m1/s1	HJURXLMWJCKIJE-CQSZACIVSA-N	555027	(2R)—N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 3	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555027&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540503	471695784							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170724	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3	FDLRDRBESBJAAV-UHFFFAOYSA-N	555028	US11339151, Example 4::US11339151, Example 40	5-hydroxytryptamine receptor 2A	Human	 0.400								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555028&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540501	471695785							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170725	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3	FDLRDRBESBJAAV-UHFFFAOYSA-N	555028	US11339151, Example 4::US11339151, Example 40	5-hydroxytryptamine receptor 7	Homo sapiens	 0.700								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555028&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540501	471695785							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170726	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3	FDLRDRBESBJAAV-UHFFFAOYSA-N	555028	US11339151, Example 4::US11339151, Example 40	D(2) dopamine receptor	Homo sapiens	 267								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555028&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540501	471695785							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170727	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)CCC(=O)OC	InChI=1S/C22H30FN3O5/c1-3-26(22(29)18(27)6-7-20(28)30-2)13-12-25-10-8-15(9-11-25)21-17-5-4-16(23)14-19(17)31-24-21/h4-5,14-15,18,27H,3,6-13H2,1-2H3	ULFZVKKURLBXLU-UHFFFAOYSA-N	555029	US11339151, Example 5	5-hydroxytryptamine receptor 2A	Human	 0.600								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555029&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552395	471695786							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170728	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)CCC(=O)OC	InChI=1S/C22H30FN3O5/c1-3-26(22(29)18(27)6-7-20(28)30-2)13-12-25-10-8-15(9-11-25)21-17-5-4-16(23)14-19(17)31-24-21/h4-5,14-15,18,27H,3,6-13H2,1-2H3	ULFZVKKURLBXLU-UHFFFAOYSA-N	555029	US11339151, Example 5	5-hydroxytryptamine receptor 7	Homo sapiens	 2.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555029&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552395	471695786							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170729	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)CCC(=O)OC	InChI=1S/C22H30FN3O5/c1-3-26(22(29)18(27)6-7-20(28)30-2)13-12-25-10-8-15(9-11-25)21-17-5-4-16(23)14-19(17)31-24-21/h4-5,14-15,18,27H,3,6-13H2,1-2H3	ULFZVKKURLBXLU-UHFFFAOYSA-N	555029	US11339151, Example 5	D(2) dopamine receptor	Homo sapiens	 116								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555029&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552395	471695786							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170730	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)(C)O	InChI=1S/C20H28FN3O3/c1-4-24(19(25)20(2,3)26)12-11-23-9-7-14(8-10-23)18-16-6-5-15(21)13-17(16)27-22-18/h5-6,13-14,26H,4,7-12H2,1-3H3	KKHDVTQDKZDTLG-UHFFFAOYSA-N	555030	US11339151, Example 6	5-hydroxytryptamine receptor 2A	Human	 0.800								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555030&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552398	471695787							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170731	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)(C)O	InChI=1S/C20H28FN3O3/c1-4-24(19(25)20(2,3)26)12-11-23-9-7-14(8-10-23)18-16-6-5-15(21)13-17(16)27-22-18/h5-6,13-14,26H,4,7-12H2,1-3H3	KKHDVTQDKZDTLG-UHFFFAOYSA-N	555030	US11339151, Example 6	5-hydroxytryptamine receptor 7	Homo sapiens	 5.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555030&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552398	471695787							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170732	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)(C)O	InChI=1S/C20H28FN3O3/c1-4-24(19(25)20(2,3)26)12-11-23-9-7-14(8-10-23)18-16-6-5-15(21)13-17(16)27-22-18/h5-6,13-14,26H,4,7-12H2,1-3H3	KKHDVTQDKZDTLG-UHFFFAOYSA-N	555030	US11339151, Example 6	D(2) dopamine receptor	Homo sapiens	 278								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555030&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552398	471695787							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170733	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)(C)CO	InChI=1S/C21H30FN3O3/c1-4-25(20(27)21(2,3)14-26)12-11-24-9-7-15(8-10-24)19-17-6-5-16(22)13-18(17)28-23-19/h5-6,13,15,26H,4,7-12,14H2,1-3H3	VUIPRPLRHSZXDX-UHFFFAOYSA-N	555031	US11339151, Example 7	5-hydroxytryptamine receptor 2A	Human	 0.200								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555031&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552393	471695788							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170734	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)(C)CO	InChI=1S/C21H30FN3O3/c1-4-25(20(27)21(2,3)14-26)12-11-24-9-7-15(8-10-24)19-17-6-5-16(22)13-18(17)28-23-19/h5-6,13,15,26H,4,7-12,14H2,1-3H3	VUIPRPLRHSZXDX-UHFFFAOYSA-N	555031	US11339151, Example 7	5-hydroxytryptamine receptor 7	Homo sapiens	 1.000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555031&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552393	471695788							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170735	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)(C)CO	InChI=1S/C21H30FN3O3/c1-4-25(20(27)21(2,3)14-26)12-11-24-9-7-15(8-10-24)19-17-6-5-16(22)13-18(17)28-23-19/h5-6,13,15,26H,4,7-12,14H2,1-3H3	VUIPRPLRHSZXDX-UHFFFAOYSA-N	555031	US11339151, Example 7	D(2) dopamine receptor	Homo sapiens	 79.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555031&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552393	471695788							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170736	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C(C)C	InChI=1S/C21H30FN3O3/c1-4-25(21(27)20(26)14(2)3)12-11-24-9-7-15(8-10-24)19-17-6-5-16(22)13-18(17)28-23-19/h5-6,13-15,20,26H,4,7-12H2,1-3H3	GFMBUKFDHKZBGH-UHFFFAOYSA-N	555032	US11339151, Example 8	5-hydroxytryptamine receptor 2A	Human	 1.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555032&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552397	471695789							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170737	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C(C)C	InChI=1S/C21H30FN3O3/c1-4-25(21(27)20(26)14(2)3)12-11-24-9-7-15(8-10-24)19-17-6-5-16(22)13-18(17)28-23-19/h5-6,13-15,20,26H,4,7-12H2,1-3H3	GFMBUKFDHKZBGH-UHFFFAOYSA-N	555032	US11339151, Example 8	5-hydroxytryptamine receptor 7	Homo sapiens	 6.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555032&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552397	471695789							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170738	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C(C)C	InChI=1S/C21H30FN3O3/c1-4-25(21(27)20(26)14(2)3)12-11-24-9-7-15(8-10-24)19-17-6-5-16(22)13-18(17)28-23-19/h5-6,13-15,20,26H,4,7-12H2,1-3H3	GFMBUKFDHKZBGH-UHFFFAOYSA-N	555032	US11339151, Example 8	D(2) dopamine receptor	Homo sapiens	 294								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555032&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552397	471695789							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170739	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CCC(O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3	VXWNWYXXDJFKLS-UHFFFAOYSA-N	555033	US11339151, Example 9	5-hydroxytryptamine receptor 2A	Human	 0.400								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555033&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695790							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170740	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CCC(O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3	VXWNWYXXDJFKLS-UHFFFAOYSA-N	555033	US11339151, Example 9	5-hydroxytryptamine receptor 7	Homo sapiens	 1.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555033&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695790							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170741	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CCC(O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3	VXWNWYXXDJFKLS-UHFFFAOYSA-N	555033	US11339151, Example 9	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555033&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695790							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170742	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CC(C)O	InChI=1S/C20H28FN3O3/c1-3-24(19(26)12-14(2)25)11-10-23-8-6-15(7-9-23)20-17-5-4-16(21)13-18(17)27-22-20/h4-5,13-15,25H,3,6-12H2,1-2H3	ADHQMOBSCUKLBQ-UHFFFAOYSA-N	555034	US11339151, Example 10	5-hydroxytryptamine receptor 2A	Human	 1.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555034&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552394	471695791							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170743	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CC(C)O	InChI=1S/C20H28FN3O3/c1-3-24(19(26)12-14(2)25)11-10-23-8-6-15(7-9-23)20-17-5-4-16(21)13-18(17)27-22-20/h4-5,13-15,25H,3,6-12H2,1-2H3	ADHQMOBSCUKLBQ-UHFFFAOYSA-N	555034	US11339151, Example 10	5-hydroxytryptamine receptor 7	Homo sapiens	 2.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555034&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552394	471695791							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170744	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CC(C)O	InChI=1S/C20H28FN3O3/c1-3-24(19(26)12-14(2)25)11-10-23-8-6-15(7-9-23)20-17-5-4-16(21)13-18(17)27-22-20/h4-5,13-15,25H,3,6-12H2,1-2H3	ADHQMOBSCUKLBQ-UHFFFAOYSA-N	555034	US11339151, Example 10	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555034&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552394	471695791							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170745	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCOCC1	InChI=1S/C22H30FN3O4/c1-2-26(21(27)22(28)7-13-29-14-8-22)12-11-25-9-5-16(6-10-25)20-18-4-3-17(23)15-19(18)30-24-20/h3-4,15-16,28H,2,5-14H2,1H3	MWUUTPCYIHCLOP-UHFFFAOYSA-N	555035	US11339151, Example 11	5-hydroxytryptamine receptor 2A	Human	 1.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555035&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163791103	471695792							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170746	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCOCC1	InChI=1S/C22H30FN3O4/c1-2-26(21(27)22(28)7-13-29-14-8-22)12-11-25-9-5-16(6-10-25)20-18-4-3-17(23)15-19(18)30-24-20/h3-4,15-16,28H,2,5-14H2,1H3	MWUUTPCYIHCLOP-UHFFFAOYSA-N	555035	US11339151, Example 11	5-hydroxytryptamine receptor 7	Homo sapiens	 5.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555035&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163791103	471695792							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170747	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCOCC1	InChI=1S/C22H30FN3O4/c1-2-26(21(27)22(28)7-13-29-14-8-22)12-11-25-9-5-16(6-10-25)20-18-4-3-17(23)15-19(18)30-24-20/h3-4,15-16,28H,2,5-14H2,1H3	MWUUTPCYIHCLOP-UHFFFAOYSA-N	555035	US11339151, Example 11	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555035&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163791103	471695792							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170748	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CO	InChI=1S/C18H24FN3O3/c1-2-22(17(24)12-23)10-9-21-7-5-13(6-8-21)18-15-4-3-14(19)11-16(15)25-20-18/h3-4,11,13,23H,2,5-10,12H2,1H3	JYAPUSNOOULIIG-UHFFFAOYSA-N	555036	US11339151, Example 12	5-hydroxytryptamine receptor 2A	Human	 1.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555036&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552386	471695793							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170749	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CO	InChI=1S/C18H24FN3O3/c1-2-22(17(24)12-23)10-9-21-7-5-13(6-8-21)18-15-4-3-14(19)11-16(15)25-20-18/h3-4,11,13,23H,2,5-10,12H2,1H3	JYAPUSNOOULIIG-UHFFFAOYSA-N	555036	US11339151, Example 12	5-hydroxytryptamine receptor 7	Homo sapiens	 6.90								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555036&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552386	471695793							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170750	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CO	InChI=1S/C18H24FN3O3/c1-2-22(17(24)12-23)10-9-21-7-5-13(6-8-21)18-15-4-3-14(19)11-16(15)25-20-18/h3-4,11,13,23H,2,5-10,12H2,1H3	JYAPUSNOOULIIG-UHFFFAOYSA-N	555036	US11339151, Example 12	D(2) dopamine receptor	Homo sapiens	 711								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555036&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552386	471695793							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170751	CCN(CCN1CCC(CC1)c1noc2cc(F)c(C)cc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-4-24(20(26)14(3)25)10-9-23-7-5-15(6-8-23)19-16-11-13(2)17(21)12-18(16)27-22-19/h11-12,14-15,25H,4-10H2,1-3H3/t14-/m0/s1	AUXKYMACGZAJNK-AWEZNQCLSA-N	555037	US11339151, Example 13	5-hydroxytryptamine receptor 2A	Human	 4.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555037&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552385	471695794							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170752	CCN(CCN1CCC(CC1)c1noc2cc(F)c(C)cc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-4-24(20(26)14(3)25)10-9-23-7-5-15(6-8-23)19-16-11-13(2)17(21)12-18(16)27-22-19/h11-12,14-15,25H,4-10H2,1-3H3/t14-/m0/s1	AUXKYMACGZAJNK-AWEZNQCLSA-N	555037	US11339151, Example 13	5-hydroxytryptamine receptor 7	Homo sapiens	 20.3								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555037&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552385	471695794							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170753	CCN(CCN1CCC(CC1)c1noc2cc(F)c(C)cc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-4-24(20(26)14(3)25)10-9-23-7-5-15(6-8-23)19-16-11-13(2)17(21)12-18(16)27-22-19/h11-12,14-15,25H,4-10H2,1-3H3/t14-/m0/s1	AUXKYMACGZAJNK-AWEZNQCLSA-N	555037	US11339151, Example 13	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555037&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552385	471695794							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170754	CCN(CCN1CCC(CC1)c1noc2ccc(C)cc12)C(=O)[C@H](C)O	InChI=1S/C20H29N3O3/c1-4-23(20(25)15(3)24)12-11-22-9-7-16(8-10-22)19-17-13-14(2)5-6-18(17)26-21-19/h5-6,13,15-16,24H,4,7-12H2,1-3H3/t15-/m0/s1	IYCHAMBXIBWQLQ-HNNXBMFYSA-N	555038	US11339151, Example 14	5-hydroxytryptamine receptor 2A	Human	 5.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555038&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552387	471695795							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170755	CCN(CCN1CCC(CC1)c1noc2ccc(C)cc12)C(=O)[C@H](C)O	InChI=1S/C20H29N3O3/c1-4-23(20(25)15(3)24)12-11-22-9-7-16(8-10-22)19-17-13-14(2)5-6-18(17)26-21-19/h5-6,13,15-16,24H,4,7-12H2,1-3H3/t15-/m0/s1	IYCHAMBXIBWQLQ-HNNXBMFYSA-N	555038	US11339151, Example 14	5-hydroxytryptamine receptor 7	Homo sapiens	 14.6								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555038&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552387	471695795							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170756	CCN(CCN1CCC(CC1)c1noc2ccc(C)cc12)C(=O)[C@H](C)O	InChI=1S/C20H29N3O3/c1-4-23(20(25)15(3)24)12-11-22-9-7-16(8-10-22)19-17-13-14(2)5-6-18(17)26-21-19/h5-6,13,15-16,24H,4,7-12H2,1-3H3/t15-/m0/s1	IYCHAMBXIBWQLQ-HNNXBMFYSA-N	555038	US11339151, Example 14	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555038&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552387	471695795							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170757	CCN(CCN1CCC(CC1)c1noc2cc(Cl)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H26ClN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	OOYRRNBZFIMBTM-ZDUSSCGKSA-N	555039	US11339151, Example 15	5-hydroxytryptamine receptor 2A	Human	 4.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555039&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163844521	471695796							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170758	CCN(CCN1CCC(CC1)c1noc2cc(Cl)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H26ClN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	OOYRRNBZFIMBTM-ZDUSSCGKSA-N	555039	US11339151, Example 15	5-hydroxytryptamine receptor 7	Homo sapiens	 26.4								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555039&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163844521	471695796							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170759	CCN(CCN1CCC(CC1)c1noc2cc(Cl)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H26ClN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	OOYRRNBZFIMBTM-ZDUSSCGKSA-N	555039	US11339151, Example 15	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555039&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163844521	471695796							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170760	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	FDLRDRBESBJAAV-ZDUSSCGKSA-N	555040	(2S)—N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 16	5-hydroxytryptamine receptor 2A	Human	 2.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555040&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540500	471695797							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170761	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	FDLRDRBESBJAAV-ZDUSSCGKSA-N	555040	(2S)—N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 16	5-hydroxytryptamine receptor 7	Homo sapiens	 5.90								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555040&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540500	471695797							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170762	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	FDLRDRBESBJAAV-ZDUSSCGKSA-N	555040	(2S)—N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 16	D(2) dopamine receptor	Homo sapiens	 389								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555040&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540500	471695797							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170763	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CCO	InChI=1S/C19H26FN3O3/c1-2-23(18(25)7-12-24)11-10-22-8-5-14(6-9-22)19-16-4-3-15(20)13-17(16)26-21-19/h3-4,13-14,24H,2,5-12H2,1H3	APSSHASNQVGROU-UHFFFAOYSA-N	555041	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-3-hydroxypropanamide::US11339151, Example 17	5-hydroxytryptamine receptor 2A	Human	 0.800								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555041&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540499	471695798							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170764	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CCO	InChI=1S/C19H26FN3O3/c1-2-23(18(25)7-12-24)11-10-22-8-5-14(6-9-22)19-16-4-3-15(20)13-17(16)26-21-19/h3-4,13-14,24H,2,5-12H2,1H3	APSSHASNQVGROU-UHFFFAOYSA-N	555041	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-3-hydroxypropanamide::US11339151, Example 17	5-hydroxytryptamine receptor 7	Homo sapiens	 4.90								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555041&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540499	471695798							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170765	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CCO	InChI=1S/C19H26FN3O3/c1-2-23(18(25)7-12-24)11-10-22-8-5-14(6-9-22)19-16-4-3-15(20)13-17(16)26-21-19/h3-4,13-14,24H,2,5-12H2,1H3	APSSHASNQVGROU-UHFFFAOYSA-N	555041	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-3-hydroxypropanamide::US11339151, Example 17	D(2) dopamine receptor	Homo sapiens	 155								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555041&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540499	471695798							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170766	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)COC	InChI=1S/C20H30FN3O4/c1-3-24(20(26)17(25)13-27-2)11-10-23-8-6-14(7-9-23)19-16-5-4-15(21)12-18(16)28-22-19/h4-5,12,14,17,19,22,25H,3,6-11,13H2,1-2H3	DEINYMBGVCCVJR-UHFFFAOYSA-N	555042	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxy-3-methoxypropanamide::US11339151, Example 18	5-hydroxytryptamine receptor 2A	Human	 2.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555042&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163513052	471695799							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170767	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)COC	InChI=1S/C20H30FN3O4/c1-3-24(20(26)17(25)13-27-2)11-10-23-8-6-14(7-9-23)19-16-5-4-15(21)12-18(16)28-22-19/h4-5,12,14,17,19,22,25H,3,6-11,13H2,1-2H3	DEINYMBGVCCVJR-UHFFFAOYSA-N	555042	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxy-3-methoxypropanamide::US11339151, Example 18	5-hydroxytryptamine receptor 7	Homo sapiens	 3.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555042&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163513052	471695799							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170768	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)COC	InChI=1S/C20H30FN3O4/c1-3-24(20(26)17(25)13-27-2)11-10-23-8-6-14(7-9-23)19-16-5-4-15(21)12-18(16)28-22-19/h4-5,12,14,17,19,22,25H,3,6-11,13H2,1-2H3	DEINYMBGVCCVJR-UHFFFAOYSA-N	555042	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxy-3-methoxypropanamide::US11339151, Example 18	D(2) dopamine receptor	Homo sapiens	 198								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555042&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163513052	471695799							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170769	CCN(CCN1CCC(CC1)c1n[nH]c2cc(F)ccc12)C(=O)C(C)O			555043	N-Ethyl-N-{2-[4-(6-fluoro-1H-indazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 19	5-hydroxytryptamine receptor 2A	Human	 1.30								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555043&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540514	471695800							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170770	CCN(CCN1CCC(CC1)c1n[nH]c2cc(F)ccc12)C(=O)C(C)O			555043	N-Ethyl-N-{2-[4-(6-fluoro-1H-indazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 19	5-hydroxytryptamine receptor 7	Homo sapiens	 2.30								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555043&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540514	471695800							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170771	CCN(CCN1CCC(CC1)c1n[nH]c2cc(F)ccc12)C(=O)C(C)O			555043	N-Ethyl-N-{2-[4-(6-fluoro-1H-indazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 19	D(2) dopamine receptor	Homo sapiens	 105								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555043&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540514	471695800							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170772	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)C(=O)[C@H](C)O			555044	(2S)—N-Ethyl-N-{2-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 20	5-hydroxytryptamine receptor 2A	Human	 0.500								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555044&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540505	471695801							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170773	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)C(=O)[C@H](C)O			555044	(2S)—N-Ethyl-N-{2-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 20	5-hydroxytryptamine receptor 7	Homo sapiens	 1.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555044&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540505	471695801							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170774	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)C(=O)[C@H](C)O			555044	(2S)—N-Ethyl-N-{2-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 20	D(2) dopamine receptor	Homo sapiens	 46.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555044&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540505	471695801							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170775	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H27FN4O2/c1-3-23(19(26)14(2)25)11-10-22-8-6-17(7-9-22)24-18-5-4-16(20)12-15(18)13-21-24/h4-5,12-14,17,25H,3,6-11H2,1-2H3/t14-/m0/s1	HJURXLMWJCKIJE-AWEZNQCLSA-N	555045	(2S)—N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 21	5-hydroxytryptamine receptor 2A	Human	 3.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555045&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540516	471695802							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170776	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H27FN4O2/c1-3-23(19(26)14(2)25)11-10-22-8-6-17(7-9-22)24-18-5-4-16(20)12-15(18)13-21-24/h4-5,12-14,17,25H,3,6-11H2,1-2H3/t14-/m0/s1	HJURXLMWJCKIJE-AWEZNQCLSA-N	555045	(2S)—N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 21	5-hydroxytryptamine receptor 7	Homo sapiens	 3.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555045&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540516	471695802							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170777	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H27FN4O2/c1-3-23(19(26)14(2)25)11-10-22-8-6-17(7-9-22)24-18-5-4-16(20)12-15(18)13-21-24/h4-5,12-14,17,25H,3,6-11H2,1-2H3/t14-/m0/s1	HJURXLMWJCKIJE-AWEZNQCLSA-N	555045	(2S)—N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 21	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555045&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540516	471695802							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170778	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)C(C)O			555046	N-Ethyl-2-hydroxy-N-{2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl}propanamide::US11339151, Example 22	5-hydroxytryptamine receptor 2A	Human	 2.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555046&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552189	471695803							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170779	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)C(C)O			555046	N-Ethyl-2-hydroxy-N-{2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl}propanamide::US11339151, Example 22	5-hydroxytryptamine receptor 7	Homo sapiens	 5.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555046&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552189	471695803							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170780	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)C(C)O			555046	N-Ethyl-2-hydroxy-N-{2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl}propanamide::US11339151, Example 22	D(2) dopamine receptor	Homo sapiens	 528								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555046&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552189	471695803							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170781	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)[C@H](C)O			555047	(2S)—N-Ethyl-2-hydroxy-N-{2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl}propanamide::US11339151, Example 23	5-hydroxytryptamine receptor 2A	Human	 1.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555047&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552404	471695804							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170782	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)[C@H](C)O			555047	(2S)—N-Ethyl-2-hydroxy-N-{2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl}propanamide::US11339151, Example 23	5-hydroxytryptamine receptor 7	Homo sapiens	 7.90								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555047&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552404	471695804							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170783	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)[C@H](C)O			555047	(2S)—N-Ethyl-2-hydroxy-N-{2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl}propanamide::US11339151, Example 23	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555047&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552404	471695804							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170784	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CC1	InChI=1S/C20H26FN3O3/c1-2-24(19(25)20(26)7-8-20)12-11-23-9-5-14(6-10-23)18-16-4-3-15(21)13-17(16)27-22-18/h3-4,13-14,26H,2,5-12H2,1H3	PYMPKOMERHZEEW-UHFFFAOYSA-N	555048	US11339151, Example 24	5-hydroxytryptamine receptor 2A	Human	 1.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555048&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163887300	471695805							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170785	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CC1	InChI=1S/C20H26FN3O3/c1-2-24(19(25)20(26)7-8-20)12-11-23-9-5-14(6-10-23)18-16-4-3-15(21)13-17(16)27-22-18/h3-4,13-14,26H,2,5-12H2,1H3	PYMPKOMERHZEEW-UHFFFAOYSA-N	555048	US11339151, Example 24	5-hydroxytryptamine receptor 7	Homo sapiens	 1.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555048&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163887300	471695805							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170786	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CC1	InChI=1S/C20H26FN3O3/c1-2-24(19(25)20(26)7-8-20)12-11-23-9-5-14(6-10-23)18-16-4-3-15(21)13-17(16)27-22-18/h3-4,13-14,26H,2,5-12H2,1H3	PYMPKOMERHZEEW-UHFFFAOYSA-N	555048	US11339151, Example 24	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555048&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163887300	471695805							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170787	CCN(CCN1CCC(CC1)c1noc2ccccc12)C(=O)C(C)O	InChI=1S/C19H27N3O3/c1-3-22(19(24)14(2)23)13-12-21-10-8-15(9-11-21)18-16-6-4-5-7-17(16)25-20-18/h4-7,14-15,23H,3,8-13H2,1-2H3	VGYBISULYWZAPR-UHFFFAOYSA-N	555049	US11339151, Example 25	5-hydroxytryptamine receptor 2A	Human	 6.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555049&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			164029881	471695806							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170788	CCN(CCN1CCC(CC1)c1noc2ccccc12)C(=O)C(C)O	InChI=1S/C19H27N3O3/c1-3-22(19(24)14(2)23)13-12-21-10-8-15(9-11-21)18-16-6-4-5-7-17(16)25-20-18/h4-7,14-15,23H,3,8-13H2,1-2H3	VGYBISULYWZAPR-UHFFFAOYSA-N	555049	US11339151, Example 25	5-hydroxytryptamine receptor 7	Homo sapiens	 7.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555049&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			164029881	471695806							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170789	CCN(CCN1CCC(CC1)c1noc2ccccc12)C(=O)C(C)O	InChI=1S/C19H27N3O3/c1-3-22(19(24)14(2)23)13-12-21-10-8-15(9-11-21)18-16-6-4-5-7-17(16)25-20-18/h4-7,14-15,23H,3,8-13H2,1-2H3	VGYBISULYWZAPR-UHFFFAOYSA-N	555049	US11339151, Example 25	D(2) dopamine receptor	Homo sapiens	 1389								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555049&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			164029881	471695806							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170790	CCN(CCN1CCN(CC1)c1noc2ccccc12)C(=O)C(C)O	InChI=1S/C18H26N4O3/c1-3-21(18(24)14(2)23)11-8-20-9-12-22(13-10-20)17-15-6-4-5-7-16(15)25-19-17/h4-7,14,23H,3,8-13H2,1-2H3	TUJFSEGSSALVST-UHFFFAOYSA-N	555050	US11339151, Example 26	5-hydroxytryptamine receptor 2A	Human	 58.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555050&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163983570	471695807							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170791	CCN(CCN1CCN(CC1)c1noc2ccccc12)C(=O)C(C)O	InChI=1S/C18H26N4O3/c1-3-21(18(24)14(2)23)11-8-20-9-12-22(13-10-20)17-15-6-4-5-7-16(15)25-19-17/h4-7,14,23H,3,8-13H2,1-2H3	TUJFSEGSSALVST-UHFFFAOYSA-N	555050	US11339151, Example 26	5-hydroxytryptamine receptor 7	Homo sapiens	 22.1								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555050&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163983570	471695807							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170792	CCN(CCN1CCN(CC1)c1noc2ccccc12)C(=O)C(C)O	InChI=1S/C18H26N4O3/c1-3-21(18(24)14(2)23)11-8-20-9-12-22(13-10-20)17-15-6-4-5-7-16(15)25-19-17/h4-7,14,23H,3,8-13H2,1-2H3	TUJFSEGSSALVST-UHFFFAOYSA-N	555050	US11339151, Example 26	D(2) dopamine receptor	Homo sapiens	>10000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555050&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163983570	471695807							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170793	CCN(CCN1CCN(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C18H25FN4O3/c1-3-22(18(25)13(2)24)9-6-21-7-10-23(11-8-21)17-15-5-4-14(19)12-16(15)26-20-17/h4-5,12-13,24H,3,6-11H2,1-2H3	XJNRZWHOAMPWIC-UHFFFAOYSA-N	555051	US11339151, Example 27	5-hydroxytryptamine receptor 2A	Human	 10.3								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555051&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			164095080	471695808							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170794	CCN(CCN1CCN(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C18H25FN4O3/c1-3-22(18(25)13(2)24)9-6-21-7-10-23(11-8-21)17-15-5-4-14(19)12-16(15)26-20-17/h4-5,12-13,24H,3,6-11H2,1-2H3	XJNRZWHOAMPWIC-UHFFFAOYSA-N	555051	US11339151, Example 27	5-hydroxytryptamine receptor 7	Homo sapiens	 11.1								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555051&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			164095080	471695808							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170795	CCN(CCN1CCN(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C18H25FN4O3/c1-3-22(18(25)13(2)24)9-6-21-7-10-23(11-8-21)17-15-5-4-14(19)12-16(15)26-20-17/h4-5,12-13,24H,3,6-11H2,1-2H3	XJNRZWHOAMPWIC-UHFFFAOYSA-N	555051	US11339151, Example 27	D(2) dopamine receptor	Homo sapiens	 2164								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555051&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			164095080	471695808							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170796	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C#C	InChI=1S/C20H24FN3O3/c1-3-17(25)20(26)24(4-2)12-11-23-9-7-14(8-10-23)19-16-6-5-15(21)13-18(16)27-22-19/h1,5-6,13-14,17,25H,4,7-12H2,2H3	XHLFNFCFXHSWCL-UHFFFAOYSA-N	555052	US11339151, Example 28	5-hydroxytryptamine receptor 2A	Human	 2.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555052&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			164092572	471695809							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170797	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C#C	InChI=1S/C20H24FN3O3/c1-3-17(25)20(26)24(4-2)12-11-23-9-7-14(8-10-23)19-16-6-5-15(21)13-18(16)27-22-19/h1,5-6,13-14,17,25H,4,7-12H2,2H3	XHLFNFCFXHSWCL-UHFFFAOYSA-N	555052	US11339151, Example 28	5-hydroxytryptamine receptor 7	Homo sapiens	 10.00								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555052&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			164092572	471695809							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170798	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C#C	InChI=1S/C20H24FN3O3/c1-3-17(25)20(26)24(4-2)12-11-23-9-7-14(8-10-23)19-16-6-5-15(21)13-18(16)27-22-19/h1,5-6,13-14,17,25H,4,7-12H2,2H3	XHLFNFCFXHSWCL-UHFFFAOYSA-N	555052	US11339151, Example 28	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555052&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			164092572	471695809							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170799	CC[C@@H](O)C(=O)N(CC)CCN1CCC(CC1)c1noc2cc(F)ccc12	InChI=1S/C20H28FN3O3/c1-3-17(25)20(26)24(4-2)12-11-23-9-7-14(8-10-23)19-16-6-5-15(21)13-18(16)27-22-19/h5-6,13-14,17,25H,3-4,7-12H2,1-2H3/t17-/m1/s1	BDJQYVCQQJQNCR-QGZVFWFLSA-N	555053	US11339151, Example 29	5-hydroxytryptamine receptor 2A	Human	 1.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555053&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163447038	471695810							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170800	CC[C@@H](O)C(=O)N(CC)CCN1CCC(CC1)c1noc2cc(F)ccc12	InChI=1S/C20H28FN3O3/c1-3-17(25)20(26)24(4-2)12-11-23-9-7-14(8-10-23)19-16-6-5-15(21)13-18(16)27-22-19/h5-6,13-14,17,25H,3-4,7-12H2,1-2H3/t17-/m1/s1	BDJQYVCQQJQNCR-QGZVFWFLSA-N	555053	US11339151, Example 29	5-hydroxytryptamine receptor 7	Homo sapiens	 2.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555053&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163447038	471695810							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170801	CC[C@@H](O)C(=O)N(CC)CCN1CCC(CC1)c1noc2cc(F)ccc12	InChI=1S/C20H28FN3O3/c1-3-17(25)20(26)24(4-2)12-11-23-9-7-14(8-10-23)19-16-6-5-15(21)13-18(16)27-22-19/h5-6,13-14,17,25H,3-4,7-12H2,1-2H3/t17-/m1/s1	BDJQYVCQQJQNCR-QGZVFWFLSA-N	555053	US11339151, Example 29	D(2) dopamine receptor	Homo sapiens	 146								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555053&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163447038	471695810							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170802	CC(O)C(=O)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)CC1CC1	InChI=1S/C21H28FN3O3/c1-14(26)21(27)25(13-15-2-3-15)11-10-24-8-6-16(7-9-24)20-18-5-4-17(22)12-19(18)28-23-20/h4-5,12,14-16,26H,2-3,6-11,13H2,1H3	SGPHWUNCTMLCQF-UHFFFAOYSA-N	555054	US11339151, Example 30	5-hydroxytryptamine receptor 2A	Human	 0.800								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555054&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552382	471695811							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170803	CC(O)C(=O)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)CC1CC1	InChI=1S/C21H28FN3O3/c1-14(26)21(27)25(13-15-2-3-15)11-10-24-8-6-16(7-9-24)20-18-5-4-17(22)12-19(18)28-23-20/h4-5,12,14-16,26H,2-3,6-11,13H2,1H3	SGPHWUNCTMLCQF-UHFFFAOYSA-N	555054	US11339151, Example 30	5-hydroxytryptamine receptor 7	Homo sapiens	 6.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555054&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552382	471695811							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170804	CC(O)C(=O)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)CC1CC1	InChI=1S/C21H28FN3O3/c1-14(26)21(27)25(13-15-2-3-15)11-10-24-8-6-16(7-9-24)20-18-5-4-17(22)12-19(18)28-23-20/h4-5,12,14-16,26H,2-3,6-11,13H2,1H3	SGPHWUNCTMLCQF-UHFFFAOYSA-N	555054	US11339151, Example 30	D(2) dopamine receptor	Homo sapiens	 153								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555054&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552382	471695811							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170805	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3	ASBHLQBMEPLWID-UHFFFAOYSA-N	555055	US11339151, Example 31	5-hydroxytryptamine receptor 2A	Human	 1.000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555055&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163432943	471695812							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170806	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3	ASBHLQBMEPLWID-UHFFFAOYSA-N	555055	US11339151, Example 31	5-hydroxytryptamine receptor 7	Homo sapiens	 1.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555055&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163432943	471695812							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170807	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3	ASBHLQBMEPLWID-UHFFFAOYSA-N	555055	US11339151, Example 31	D(2) dopamine receptor	Homo sapiens	 89.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555055&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163432943	471695812							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170808	CC(O)C(=O)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)CC#N	InChI=1S/C19H23FN4O3/c1-13(25)19(26)24(9-6-21)11-10-23-7-4-14(5-8-23)18-16-3-2-15(20)12-17(16)27-22-18/h2-3,12-14,25H,4-5,7-11H2,1H3	CPXNIAPBZOOTGJ-UHFFFAOYSA-N	555056	US11339151, Example 32	5-hydroxytryptamine receptor 2A	Human	 97.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555056&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163494983	471695813							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170809	CC(O)C(=O)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)CC#N	InChI=1S/C19H23FN4O3/c1-13(25)19(26)24(9-6-21)11-10-23-7-4-14(5-8-23)18-16-3-2-15(20)12-17(16)27-22-18/h2-3,12-14,25H,4-5,7-11H2,1H3	CPXNIAPBZOOTGJ-UHFFFAOYSA-N	555056	US11339151, Example 32	5-hydroxytryptamine receptor 7	Homo sapiens	 110								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555056&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163494983	471695813							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170810	CC(O)C(=O)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)CC#N	InChI=1S/C19H23FN4O3/c1-13(25)19(26)24(9-6-21)11-10-23-7-4-14(5-8-23)18-16-3-2-15(20)12-17(16)27-22-18/h2-3,12-14,25H,4-5,7-11H2,1H3	CPXNIAPBZOOTGJ-UHFFFAOYSA-N	555056	US11339151, Example 32	D(2) dopamine receptor	Homo sapiens	>10000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555056&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163494983	471695813							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170811	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CCCCC1O	InChI=1S/C23H32FN3O3/c1-2-27(23(29)18-5-3-4-6-20(18)28)14-13-26-11-9-16(10-12-26)22-19-8-7-17(24)15-21(19)30-25-22/h7-8,15-16,18,20,28H,2-6,9-14H2,1H3	CJCHZXCLUYLXJM-UHFFFAOYSA-N	555057	US11339151, Example 33	5-hydroxytryptamine receptor 2A	Human	 0.300								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555057&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163486634	471695814							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170812	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CCCCC1O	InChI=1S/C23H32FN3O3/c1-2-27(23(29)18-5-3-4-6-20(18)28)14-13-26-11-9-16(10-12-26)22-19-8-7-17(24)15-21(19)30-25-22/h7-8,15-16,18,20,28H,2-6,9-14H2,1H3	CJCHZXCLUYLXJM-UHFFFAOYSA-N	555057	US11339151, Example 33	5-hydroxytryptamine receptor 7	Homo sapiens	 1.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555057&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163486634	471695814							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170813	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CCCCC1O	InChI=1S/C23H32FN3O3/c1-2-27(23(29)18-5-3-4-6-20(18)28)14-13-26-11-9-16(10-12-26)22-19-8-7-17(24)15-21(19)30-25-22/h7-8,15-16,18,20,28H,2-6,9-14H2,1H3	CJCHZXCLUYLXJM-UHFFFAOYSA-N	555057	US11339151, Example 33	D(2) dopamine receptor	Homo sapiens	 55.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555057&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163486634	471695814							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170814	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C(F)(F)F	InChI=1S/C19H23F4N3O3/c1-2-26(18(28)17(27)19(21,22)23)10-9-25-7-5-12(6-8-25)16-14-4-3-13(20)11-15(14)29-24-16/h3-4,11-12,17,27H,2,5-10H2,1H3	VJYQMOSNEVQNJR-UHFFFAOYSA-N	555058	US11339151, Example 34	5-hydroxytryptamine receptor 2A	Human	 0.600								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555058&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552380	471695815							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170815	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C(F)(F)F	InChI=1S/C19H23F4N3O3/c1-2-26(18(28)17(27)19(21,22)23)10-9-25-7-5-12(6-8-25)16-14-4-3-13(20)11-15(14)29-24-16/h3-4,11-12,17,27H,2,5-10H2,1H3	VJYQMOSNEVQNJR-UHFFFAOYSA-N	555058	US11339151, Example 34	5-hydroxytryptamine receptor 7	Homo sapiens	 4.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555058&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552380	471695815							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170816	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C(F)(F)F	InChI=1S/C19H23F4N3O3/c1-2-26(18(28)17(27)19(21,22)23)10-9-25-7-5-12(6-8-25)16-14-4-3-13(20)11-15(14)29-24-16/h3-4,11-12,17,27H,2,5-10H2,1H3	VJYQMOSNEVQNJR-UHFFFAOYSA-N	555058	US11339151, Example 34	D(2) dopamine receptor	Homo sapiens	 247								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555058&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552380	471695815							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170817	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CCO	InChI=1S/C20H28FN3O3/c1-14(2)24(19(26)7-12-25)11-10-23-8-5-15(6-9-23)20-17-4-3-16(21)13-18(17)27-22-20/h3-4,13-15,25H,5-12H2,1-2H3	YQCPDRVHUVCVIN-UHFFFAOYSA-N	555059	US11339151, Example 35	5-hydroxytryptamine receptor 2A	Human	 1.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555059&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552384	471695816							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170818	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CCO	InChI=1S/C20H28FN3O3/c1-14(2)24(19(26)7-12-25)11-10-23-8-5-15(6-9-23)20-17-4-3-16(21)13-18(17)27-22-20/h3-4,13-15,25H,5-12H2,1-2H3	YQCPDRVHUVCVIN-UHFFFAOYSA-N	555059	US11339151, Example 35	5-hydroxytryptamine receptor 7	Homo sapiens	 3.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555059&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552384	471695816							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170819	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CCO	InChI=1S/C20H28FN3O3/c1-14(2)24(19(26)7-12-25)11-10-23-8-5-15(6-9-23)20-17-4-3-16(21)13-18(17)27-22-20/h3-4,13-15,25H,5-12H2,1-2H3	YQCPDRVHUVCVIN-UHFFFAOYSA-N	555059	US11339151, Example 35	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555059&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552384	471695816							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170820	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(F)(F)CO	InChI=1S/C19H24F3N3O3/c1-2-25(18(27)19(21,22)12-26)10-9-24-7-5-13(6-8-24)17-15-4-3-14(20)11-16(15)28-23-17/h3-4,11,13,26H,2,5-10,12H2,1H3	BCPXPZBIZDMKQR-UHFFFAOYSA-N	555060	US11339151, Example 36	5-hydroxytryptamine receptor 2A	Human	 0.900								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555060&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163446060	471695817							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170821	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(F)(F)CO	InChI=1S/C19H24F3N3O3/c1-2-25(18(27)19(21,22)12-26)10-9-24-7-5-13(6-8-24)17-15-4-3-14(20)11-16(15)28-23-17/h3-4,11,13,26H,2,5-10,12H2,1H3	BCPXPZBIZDMKQR-UHFFFAOYSA-N	555060	US11339151, Example 36	5-hydroxytryptamine receptor 7	Homo sapiens	 1.000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555060&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163446060	471695817							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170822	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(F)(F)CO	InChI=1S/C19H24F3N3O3/c1-2-25(18(27)19(21,22)12-26)10-9-24-7-5-13(6-8-24)17-15-4-3-14(20)11-16(15)28-23-17/h3-4,11,13,26H,2,5-10,12H2,1H3	BCPXPZBIZDMKQR-UHFFFAOYSA-N	555060	US11339151, Example 36	D(2) dopamine receptor	Homo sapiens	 80.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555060&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163446060	471695817							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170823	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)CO	InChI=1S/C20H28FN3O3/c1-3-24(20(26)14(2)13-25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12,14-15,25H,3,6-11,13H2,1-2H3	FJSMDTWYILVAAN-UHFFFAOYSA-N	555061	US11339151, Example 37	5-hydroxytryptamine receptor 2A	Human	 0.900								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555061&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163551813	471695818							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170824	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)CO	InChI=1S/C20H28FN3O3/c1-3-24(20(26)14(2)13-25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12,14-15,25H,3,6-11,13H2,1-2H3	FJSMDTWYILVAAN-UHFFFAOYSA-N	555061	US11339151, Example 37	5-hydroxytryptamine receptor 7	Homo sapiens	 1.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555061&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163551813	471695818							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170825	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)CO	InChI=1S/C20H28FN3O3/c1-3-24(20(26)14(2)13-25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12,14-15,25H,3,6-11,13H2,1-2H3	FJSMDTWYILVAAN-UHFFFAOYSA-N	555061	US11339151, Example 37	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555061&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163551813	471695818							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170826	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-3-24(20(26)14(2)25)10-4-9-23-11-7-15(8-12-23)19-17-6-5-16(21)13-18(17)27-22-19/h5-6,13-15,25H,3-4,7-12H2,1-2H3/t14-/m0/s1	PJWKDVIAVIYPPN-AWEZNQCLSA-N	555062	US11339151, Example 38	5-hydroxytryptamine receptor 2A	Human	 8.30								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555062&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163869882	471695819							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170827	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-3-24(20(26)14(2)25)10-4-9-23-11-7-15(8-12-23)19-17-6-5-16(21)13-18(17)27-22-19/h5-6,13-15,25H,3-4,7-12H2,1-2H3/t14-/m0/s1	PJWKDVIAVIYPPN-AWEZNQCLSA-N	555062	US11339151, Example 38	5-hydroxytryptamine receptor 7	Homo sapiens	 9.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555062&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163869882	471695819							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170828	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-3-24(20(26)14(2)25)10-4-9-23-11-7-15(8-12-23)19-17-6-5-16(21)13-18(17)27-22-19/h5-6,13-15,25H,3-4,7-12H2,1-2H3/t14-/m0/s1	PJWKDVIAVIYPPN-AWEZNQCLSA-N	555062	US11339151, Example 38	D(2) dopamine receptor	Homo sapiens	 352								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555062&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163869882	471695819							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170829	CCCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O3/c1-3-8-24(20(26)14(2)25)12-11-23-9-6-15(7-10-23)19-17-5-4-16(21)13-18(17)27-22-19/h4-5,13-15,25H,3,6-12H2,1-2H3	IDBDRTSGQKZOSY-UHFFFAOYSA-N	555063	US11339151, Example 39	5-hydroxytryptamine receptor 2A	Human	 0.800								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555063&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163639561	471695820							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170830	CCCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O3/c1-3-8-24(20(26)14(2)25)12-11-23-9-6-15(7-10-23)19-17-5-4-16(21)13-18(17)27-22-19/h4-5,13-15,25H,3,6-12H2,1-2H3	IDBDRTSGQKZOSY-UHFFFAOYSA-N	555063	US11339151, Example 39	5-hydroxytryptamine receptor 7	Homo sapiens	 0.700								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555063&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163639561	471695820							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170831	CCCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O3/c1-3-8-24(20(26)14(2)25)12-11-23-9-6-15(7-10-23)19-17-5-4-16(21)13-18(17)27-22-19/h4-5,13-15,25H,3,6-12H2,1-2H3	IDBDRTSGQKZOSY-UHFFFAOYSA-N	555063	US11339151, Example 39	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555063&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163639561	471695820							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170832	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3	FDLRDRBESBJAAV-UHFFFAOYSA-N	555028	US11339151, Example 4::US11339151, Example 40	5-hydroxytryptamine receptor 2A	Human	 1.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555028&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540501	471695785							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170833	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3	FDLRDRBESBJAAV-UHFFFAOYSA-N	555028	US11339151, Example 4::US11339151, Example 40	5-hydroxytryptamine receptor 7	Homo sapiens	 1.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555028&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540501	471695785							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170834	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3	FDLRDRBESBJAAV-UHFFFAOYSA-N	555028	US11339151, Example 4::US11339151, Example 40	D(2) dopamine receptor	Homo sapiens	 214								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555028&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540501	471695785							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170835	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3/t14-/m0/s1	ASBHLQBMEPLWID-AWEZNQCLSA-N	555065	US11339151, Example 41	5-hydroxytryptamine receptor 2A	Human	 4.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555065&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163432941	471695821							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170836	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3/t14-/m0/s1	ASBHLQBMEPLWID-AWEZNQCLSA-N	555065	US11339151, Example 41	5-hydroxytryptamine receptor 7	Homo sapiens	 1.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555065&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163432941	471695821							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170837	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3/t14-/m0/s1	ASBHLQBMEPLWID-AWEZNQCLSA-N	555065	US11339151, Example 41	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555065&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163432941	471695821							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170838	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3/t14-/m1/s1	ASBHLQBMEPLWID-CQSZACIVSA-N	555066	US11339151, Example 42	5-hydroxytryptamine receptor 2A	Human	 2.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555066&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163432942	471695822							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170839	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3/t14-/m1/s1	ASBHLQBMEPLWID-CQSZACIVSA-N	555066	US11339151, Example 42	5-hydroxytryptamine receptor 7	Homo sapiens	 2.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555066&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163432942	471695822							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170840	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3/t14-/m1/s1	ASBHLQBMEPLWID-CQSZACIVSA-N	555066	US11339151, Example 42	D(2) dopamine receptor	Homo sapiens	 74.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555066&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163432942	471695822							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170841	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H]1CC[C@H](O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3/t17-,19-	VXWNWYXXDJFKLS-UAPYVXQJSA-N	555067	US11339151, Example 43	5-hydroxytryptamine receptor 2A	Human	 1.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555067&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695823							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170842	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H]1CC[C@H](O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3/t17-,19-	VXWNWYXXDJFKLS-UAPYVXQJSA-N	555067	US11339151, Example 43	5-hydroxytryptamine receptor 7	Homo sapiens	 4.30								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555067&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695823							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170843	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H]1CC[C@H](O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3/t17-,19-	VXWNWYXXDJFKLS-UAPYVXQJSA-N	555067	US11339151, Example 43	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555067&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695823							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170844	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H]1CC[C@H](O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3/t17-,19+	VXWNWYXXDJFKLS-IZAXUBKRSA-N	555068	US11339151, Example 44	5-hydroxytryptamine receptor 2A	Human	 0.500								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555068&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695824							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170845	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H]1CC[C@H](O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3/t17-,19+	VXWNWYXXDJFKLS-IZAXUBKRSA-N	555068	US11339151, Example 44	5-hydroxytryptamine receptor 7	Homo sapiens	 3.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555068&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695824							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170846	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H]1CC[C@H](O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3/t17-,19+	VXWNWYXXDJFKLS-IZAXUBKRSA-N	555068	US11339151, Example 44	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555068&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695824							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170847	CCN(CCN1CCC(CC1)c1noc2ccc(F)cc12)C(=O)[C@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-12-15(20)4-5-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	OCFYVNCLSBVCRR-ZDUSSCGKSA-N	555069	US11339151, Example 45	5-hydroxytryptamine receptor 2A	Human	 15.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555069&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163829252	471695825							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170848	CCN(CCN1CCC(CC1)c1noc2ccc(F)cc12)C(=O)[C@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-12-15(20)4-5-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	OCFYVNCLSBVCRR-ZDUSSCGKSA-N	555069	US11339151, Example 45	5-hydroxytryptamine receptor 7	Homo sapiens	 22.6								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555069&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163829252	471695825							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170849	CCN(CCN1CCC(CC1)c1noc2ccc(F)cc12)C(=O)[C@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-12-15(20)4-5-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	OCFYVNCLSBVCRR-ZDUSSCGKSA-N	555069	US11339151, Example 45	D(2) dopamine receptor	Homo sapiens	>300								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555069&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163829252	471695825							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170850	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CC(O)C1	InChI=1S/C21H28FN3O3/c1-2-25(21(27)15-11-17(26)12-15)10-9-24-7-5-14(6-8-24)20-18-4-3-16(22)13-19(18)28-23-20/h3-4,13-15,17,26H,2,5-12H2,1H3	TVUOUHQBOXWHNG-UHFFFAOYSA-N	555070	US11339151, Example 46	5-hydroxytryptamine receptor 2A	Human	 0.900								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555070&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163985344	471695826							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170851	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CC(O)C1	InChI=1S/C21H28FN3O3/c1-2-25(21(27)15-11-17(26)12-15)10-9-24-7-5-14(6-8-24)20-18-4-3-16(22)13-19(18)28-23-20/h3-4,13-15,17,26H,2,5-12H2,1H3	TVUOUHQBOXWHNG-UHFFFAOYSA-N	555070	US11339151, Example 46	5-hydroxytryptamine receptor 7	Homo sapiens	 4.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555070&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163985344	471695826							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170852	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CC(O)C1	InChI=1S/C21H28FN3O3/c1-2-25(21(27)15-11-17(26)12-15)10-9-24-7-5-14(6-8-24)20-18-4-3-16(22)13-19(18)28-23-20/h3-4,13-15,17,26H,2,5-12H2,1H3	TVUOUHQBOXWHNG-UHFFFAOYSA-N	555070	US11339151, Example 46	D(2) dopamine receptor	Homo sapiens	 75.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555070&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163985344	471695826							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170853	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)CCO	InChI=1S/C20H29N3O2/c1-2-23(20(25)9-14-24)13-12-22-10-7-16(8-11-22)18-15-21-19-6-4-3-5-17(18)19/h3-6,15-16,21,24H,2,7-14H2,1H3	WJBOFUDAMNIJRL-UHFFFAOYSA-N	555071	US11339151, Example 47	5-hydroxytryptamine receptor 2A	Human	 2.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555071&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552504	471695827							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170854	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)CCO	InChI=1S/C20H29N3O2/c1-2-23(20(25)9-14-24)13-12-22-10-7-16(8-11-22)18-15-21-19-6-4-3-5-17(18)19/h3-6,15-16,21,24H,2,7-14H2,1H3	WJBOFUDAMNIJRL-UHFFFAOYSA-N	555071	US11339151, Example 47	5-hydroxytryptamine receptor 7	Homo sapiens	 8.90								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555071&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552504	471695827							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170855	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)CCO	InChI=1S/C20H29N3O2/c1-2-23(20(25)9-14-24)13-12-22-10-7-16(8-11-22)18-15-21-19-6-4-3-5-17(18)19/h3-6,15-16,21,24H,2,7-14H2,1H3	WJBOFUDAMNIJRL-UHFFFAOYSA-N	555071	US11339151, Example 47	D(2) dopamine receptor	Homo sapiens	 457								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555071&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552504	471695827							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170856	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)C(=O)CCO	InChI=1S/C20H28FN3O2/c1-2-24(20(26)7-12-25)11-10-23-8-5-15(6-9-23)18-14-22-19-13-16(21)3-4-17(18)19/h3-4,13-15,22,25H,2,5-12H2,1H3	KAAGJIUPRMXDTG-UHFFFAOYSA-N	555072	US11339151, Example 48	5-hydroxytryptamine receptor 2A	Human	 0.600								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555072&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163699809	471695828							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170857	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)C(=O)CCO	InChI=1S/C20H28FN3O2/c1-2-24(20(26)7-12-25)11-10-23-8-5-15(6-9-23)18-14-22-19-13-16(21)3-4-17(18)19/h3-4,13-15,22,25H,2,5-12H2,1H3	KAAGJIUPRMXDTG-UHFFFAOYSA-N	555072	US11339151, Example 48	5-hydroxytryptamine receptor 7	Homo sapiens	 2.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555072&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163699809	471695828							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170858	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)C(=O)CCO	InChI=1S/C20H28FN3O2/c1-2-24(20(26)7-12-25)11-10-23-8-5-15(6-9-23)18-14-22-19-13-16(21)3-4-17(18)19/h3-4,13-15,22,25H,2,5-12H2,1H3	KAAGJIUPRMXDTG-UHFFFAOYSA-N	555072	US11339151, Example 48	D(2) dopamine receptor	Homo sapiens	 80.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555072&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163699809	471695828							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170859	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)[C@@H](C)O			555073	US11339151, Example 49	5-hydroxytryptamine receptor 2A	Human	 9.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555073&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163486284	471695829							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170860	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)[C@@H](C)O			555073	US11339151, Example 49	5-hydroxytryptamine receptor 7	Homo sapiens	 22.6								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555073&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163486284	471695829							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170861	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)[C@@H](C)O			555073	US11339151, Example 49	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555073&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163486284	471695829							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170862	CCN(CCN1CCC(CC1)n1ccc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O2/c1-3-23(20(26)15(2)25)13-12-22-9-7-18(8-10-22)24-11-6-16-14-17(21)4-5-19(16)24/h4-6,11,14-15,18,25H,3,7-10,12-13H2,1-2H3	CJXRRILKADPIQO-UHFFFAOYSA-N	555074	US11339151, Example 50	5-hydroxytryptamine receptor 2A	Human	 4.00								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555074&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163487669	471695830							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170863	CCN(CCN1CCC(CC1)n1ccc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O2/c1-3-23(20(26)15(2)25)13-12-22-9-7-18(8-10-22)24-11-6-16-14-17(21)4-5-19(16)24/h4-6,11,14-15,18,25H,3,7-10,12-13H2,1-2H3	CJXRRILKADPIQO-UHFFFAOYSA-N	555074	US11339151, Example 50	5-hydroxytryptamine receptor 7	Homo sapiens	 13.5								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555074&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163487669	471695830							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170864	CCN(CCN1CCC(CC1)n1ccc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O2/c1-3-23(20(26)15(2)25)13-12-22-9-7-18(8-10-22)24-11-6-16-14-17(21)4-5-19(16)24/h4-6,11,14-15,18,25H,3,7-10,12-13H2,1-2H3	CJXRRILKADPIQO-UHFFFAOYSA-N	555074	US11339151, Example 50	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555074&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163487669	471695830							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170865	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C18H26FN3O4S/c1-2-22(27(24,25)12-11-23)10-9-21-7-5-14(6-8-21)18-16-4-3-15(19)13-17(16)26-20-18/h3-4,13-14,23H,2,5-12H2,1H3	LAUGNMXDAVIKFQ-UHFFFAOYSA-N	555075	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxyethane-1-sulfonamide::US11339151, Example 51	5-hydroxytryptamine receptor 2A	Human	 2.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555075&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540520	471695831							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170866	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C18H26FN3O4S/c1-2-22(27(24,25)12-11-23)10-9-21-7-5-14(6-8-21)18-16-4-3-15(19)13-17(16)26-20-18/h3-4,13-14,23H,2,5-12H2,1H3	LAUGNMXDAVIKFQ-UHFFFAOYSA-N	555075	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxyethane-1-sulfonamide::US11339151, Example 51	5-hydroxytryptamine receptor 7	Homo sapiens	 1.90								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555075&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540520	471695831							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170867	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C18H26FN3O4S/c1-2-22(27(24,25)12-11-23)10-9-21-7-5-14(6-8-21)18-16-4-3-15(19)13-17(16)26-20-18/h3-4,13-14,23H,2,5-12H2,1H3	LAUGNMXDAVIKFQ-UHFFFAOYSA-N	555075	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxyethane-1-sulfonamide::US11339151, Example 51	D(2) dopamine receptor	Homo sapiens	 309								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555075&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540520	471695831							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170868	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H28FN3O4S/c1-3-23(28(25,26)14(2)13-24)11-10-22-8-6-15(7-9-22)19-17-5-4-16(20)12-18(17)27-21-19/h4-5,12,14-15,24H,3,6-11,13H2,1-2H3	RRAQJOVLPLUMFT-UHFFFAOYSA-N	555076	US11339151, Example 52	5-hydroxytryptamine receptor 2A	Human	 298								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555076&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163941124	471695832							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170869	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H28FN3O4S/c1-3-23(28(25,26)14(2)13-24)11-10-22-8-6-15(7-9-22)19-17-5-4-16(20)12-18(17)27-21-19/h4-5,12,14-15,24H,3,6-11,13H2,1-2H3	RRAQJOVLPLUMFT-UHFFFAOYSA-N	555076	US11339151, Example 52	5-hydroxytryptamine receptor 7	Homo sapiens	 333								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555076&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163941124	471695832							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170870	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H28FN3O4S/c1-3-23(28(25,26)14(2)13-24)11-10-22-8-6-15(7-9-22)19-17-5-4-16(20)12-18(17)27-21-19/h4-5,12,14-15,24H,3,6-11,13H2,1-2H3	RRAQJOVLPLUMFT-UHFFFAOYSA-N	555076	US11339151, Example 52	D(2) dopamine receptor	Homo sapiens	>10000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555076&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163941124	471695832							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170871	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O4S/c1-2-23(28(25,26)13-12-24)9-3-8-22-10-6-15(7-11-22)19-17-5-4-16(20)14-18(17)27-21-19/h4-5,14-15,24H,2-3,6-13H2,1H3	CCDSAGIQOBMXST-UHFFFAOYSA-N	555077	US11339151, Example 53	5-hydroxytryptamine receptor 2A	Human	 1.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555077&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552225	471695833							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170872	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O4S/c1-2-23(28(25,26)13-12-24)9-3-8-22-10-6-15(7-11-22)19-17-5-4-16(20)14-18(17)27-21-19/h4-5,14-15,24H,2-3,6-13H2,1H3	CCDSAGIQOBMXST-UHFFFAOYSA-N	555077	US11339151, Example 53	5-hydroxytryptamine receptor 7	Homo sapiens	 1.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555077&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552225	471695833							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170873	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O4S/c1-2-23(28(25,26)13-12-24)9-3-8-22-10-6-15(7-11-22)19-17-5-4-16(20)14-18(17)27-21-19/h4-5,14-15,24H,2-3,6-13H2,1H3	CCDSAGIQOBMXST-UHFFFAOYSA-N	555077	US11339151, Example 53	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555077&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552225	471695833							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170874	CCN(CCCN1CCC(CC1)c1noc2ccccc12)S(=O)(=O)C(C)CO	InChI=1S/C20H31N3O4S/c1-3-23(28(25,26)16(2)15-24)12-6-11-22-13-9-17(10-14-22)20-18-7-4-5-8-19(18)27-21-20/h4-5,7-8,16-17,24H,3,6,9-15H2,1-2H3	VANOULQUECNACR-UHFFFAOYSA-N	555078	US11339151, Example 54	5-hydroxytryptamine receptor 2A	Human	 2.00								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555078&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			164022293	471695834							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170875	CCN(CCCN1CCC(CC1)c1noc2ccccc12)S(=O)(=O)C(C)CO	InChI=1S/C20H31N3O4S/c1-3-23(28(25,26)16(2)15-24)12-6-11-22-13-9-17(10-14-22)20-18-7-4-5-8-19(18)27-21-20/h4-5,7-8,16-17,24H,3,6,9-15H2,1-2H3	VANOULQUECNACR-UHFFFAOYSA-N	555078	US11339151, Example 54	5-hydroxytryptamine receptor 7	Homo sapiens	 2.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555078&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			164022293	471695834							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170876	CCN(CCCN1CCC(CC1)c1noc2ccccc12)S(=O)(=O)C(C)CO	InChI=1S/C20H31N3O4S/c1-3-23(28(25,26)16(2)15-24)12-6-11-22-13-9-17(10-14-22)20-18-7-4-5-8-19(18)27-21-20/h4-5,7-8,16-17,24H,3,6,9-15H2,1-2H3	VANOULQUECNACR-UHFFFAOYSA-N	555078	US11339151, Example 54	D(2) dopamine receptor	Homo sapiens	 116								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555078&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			164022293	471695834							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170877	CCN(CCCN1CCN(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H29FN4O4S/c1-3-24(29(26,27)15(2)14-25)8-4-7-22-9-11-23(12-10-22)19-17-6-5-16(20)13-18(17)28-21-19/h5-6,13,15,25H,3-4,7-12,14H2,1-2H3	UCUKBRIYXZZGPO-UHFFFAOYSA-N	555079	US11339151, Example 55	5-hydroxytryptamine receptor 2A	Human	 1.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555079&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163993670	471695835							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170878	CCN(CCCN1CCN(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H29FN4O4S/c1-3-24(29(26,27)15(2)14-25)8-4-7-22-9-11-23(12-10-22)19-17-6-5-16(20)13-18(17)28-21-19/h5-6,13,15,25H,3-4,7-12,14H2,1-2H3	UCUKBRIYXZZGPO-UHFFFAOYSA-N	555079	US11339151, Example 55	5-hydroxytryptamine receptor 7	Homo sapiens	 0.100								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555079&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163993670	471695835							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170879	CCN(CCCN1CCN(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H29FN4O4S/c1-3-24(29(26,27)15(2)14-25)8-4-7-22-9-11-23(12-10-22)19-17-6-5-16(20)13-18(17)28-21-19/h5-6,13,15,25H,3-4,7-12,14H2,1-2H3	UCUKBRIYXZZGPO-UHFFFAOYSA-N	555079	US11339151, Example 55	D(2) dopamine receptor	Homo sapiens	 78.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555079&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163993670	471695835							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170880	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C20H30FN3O4S/c1-3-24(29(26,27)15(2)14-25)10-4-9-23-11-7-16(8-12-23)20-18-6-5-17(21)13-19(18)28-22-20/h5-6,13,15-16,25H,3-4,7-12,14H2,1-2H3	QBAFYRJKNUYHMO-UHFFFAOYSA-N	555080	US11339151, Example 56	5-hydroxytryptamine receptor 2A	Human	 1.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555080&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163890379	471695836							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170881	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C20H30FN3O4S/c1-3-24(29(26,27)15(2)14-25)10-4-9-23-11-7-16(8-12-23)20-18-6-5-17(21)13-19(18)28-22-20/h5-6,13,15-16,25H,3-4,7-12,14H2,1-2H3	QBAFYRJKNUYHMO-UHFFFAOYSA-N	555080	US11339151, Example 56	5-hydroxytryptamine receptor 7	Homo sapiens	 0.400								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555080&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163890379	471695836							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170882	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C20H30FN3O4S/c1-3-24(29(26,27)15(2)14-25)10-4-9-23-11-7-16(8-12-23)20-18-6-5-17(21)13-19(18)28-22-20/h5-6,13,15-16,25H,3-4,7-12,14H2,1-2H3	QBAFYRJKNUYHMO-UHFFFAOYSA-N	555080	US11339151, Example 56	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555080&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163890379	471695836							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170883	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)S(=O)(=O)CCO	InChI=1S/C19H29N3O3S/c1-2-22(26(24,25)14-13-23)12-11-21-9-7-16(8-10-21)18-15-20-19-6-4-3-5-17(18)19/h3-6,15-16,20,23H,2,7-14H2,1H3	VLXOYOJCCCNIRP-UHFFFAOYSA-N	555081	US11339151, Example 57	5-hydroxytryptamine receptor 2A	Human	 1.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555081&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			164035772	471695837							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170884	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)S(=O)(=O)CCO	InChI=1S/C19H29N3O3S/c1-2-22(26(24,25)14-13-23)12-11-21-9-7-16(8-10-21)18-15-20-19-6-4-3-5-17(18)19/h3-6,15-16,20,23H,2,7-14H2,1H3	VLXOYOJCCCNIRP-UHFFFAOYSA-N	555081	US11339151, Example 57	5-hydroxytryptamine receptor 7	Homo sapiens	 8.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555081&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			164035772	471695837							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170885	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)S(=O)(=O)CCO	InChI=1S/C19H29N3O3S/c1-2-22(26(24,25)14-13-23)12-11-21-9-7-16(8-10-21)18-15-20-19-6-4-3-5-17(18)19/h3-6,15-16,20,23H,2,7-14H2,1H3	VLXOYOJCCCNIRP-UHFFFAOYSA-N	555081	US11339151, Example 57	D(2) dopamine receptor	Homo sapiens	 210								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555081&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			164035772	471695837							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170886	CCN(CCN1CCC(CC1)c1noc2cc(F)c(C)cc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O4S/c1-3-23(28(25,26)11-10-24)9-8-22-6-4-15(5-7-22)19-16-12-14(2)17(20)13-18(16)27-21-19/h12-13,15,24H,3-11H2,1-2H3	RZMZSGLGLBSHEO-UHFFFAOYSA-N	555082	US11339151, Example 58	5-hydroxytryptamine receptor 2A	Human	 53.2								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555082&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552373	471695838							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170887	CCN(CCN1CCC(CC1)c1noc2cc(F)c(C)cc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O4S/c1-3-23(28(25,26)11-10-24)9-8-22-6-4-15(5-7-22)19-16-12-14(2)17(20)13-18(16)27-21-19/h12-13,15,24H,3-11H2,1-2H3	RZMZSGLGLBSHEO-UHFFFAOYSA-N	555082	US11339151, Example 58	5-hydroxytryptamine receptor 7	Homo sapiens	 19.4								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555082&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552373	471695838							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170888	CCN(CCN1CCC(CC1)c1noc2cc(F)c(C)cc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O4S/c1-3-23(28(25,26)11-10-24)9-8-22-6-4-15(5-7-22)19-16-12-14(2)17(20)13-18(16)27-21-19/h12-13,15,24H,3-11H2,1-2H3	RZMZSGLGLBSHEO-UHFFFAOYSA-N	555082	US11339151, Example 58	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555082&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552373	471695838							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170889	CCN(CCN1CCC(CC1)c1noc2ccc(C)cc12)S(=O)(=O)CCO	InChI=1S/C19H29N3O4S/c1-3-22(27(24,25)13-12-23)11-10-21-8-6-16(7-9-21)19-17-14-15(2)4-5-18(17)26-20-19/h4-5,14,16,23H,3,6-13H2,1-2H3	DMCYGCVJPSDQON-UHFFFAOYSA-N	555083	US11339151, Example 59	5-hydroxytryptamine receptor 2A	Human	 44.7								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555083&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552374	471695839							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170890	CCN(CCN1CCC(CC1)c1noc2ccc(C)cc12)S(=O)(=O)CCO	InChI=1S/C19H29N3O4S/c1-3-22(27(24,25)13-12-23)11-10-21-8-6-16(7-9-21)19-17-14-15(2)4-5-18(17)26-20-19/h4-5,14,16,23H,3,6-13H2,1-2H3	DMCYGCVJPSDQON-UHFFFAOYSA-N	555083	US11339151, Example 59	5-hydroxytryptamine receptor 7	Homo sapiens	 13.6								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555083&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552374	471695839							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170891	CCN(CCN1CCC(CC1)c1noc2ccc(C)cc12)S(=O)(=O)CCO	InChI=1S/C19H29N3O4S/c1-3-22(27(24,25)13-12-23)11-10-21-8-6-16(7-9-21)19-17-14-15(2)4-5-18(17)26-20-19/h4-5,14,16,23H,3,6-13H2,1-2H3	DMCYGCVJPSDQON-UHFFFAOYSA-N	555083	US11339151, Example 59	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555083&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552374	471695839							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170892	CCN(CCN1CCC(CC1)c1noc2cc(Cl)ccc12)S(=O)(=O)CCO	InChI=1S/C18H26ClN3O4S/c1-2-22(27(24,25)12-11-23)10-9-21-7-5-14(6-8-21)18-16-4-3-15(19)13-17(16)26-20-18/h3-4,13-14,23H,2,5-12H2,1H3	WKTMKMQREUNTCP-UHFFFAOYSA-N	555084	US11339151, Example 60	5-hydroxytryptamine receptor 2A	Human	 19.9								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555084&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			164065702	471695840							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170893	CCN(CCN1CCC(CC1)c1noc2cc(Cl)ccc12)S(=O)(=O)CCO	InChI=1S/C18H26ClN3O4S/c1-2-22(27(24,25)12-11-23)10-9-21-7-5-14(6-8-21)18-16-4-3-15(19)13-17(16)26-20-18/h3-4,13-14,23H,2,5-12H2,1H3	WKTMKMQREUNTCP-UHFFFAOYSA-N	555084	US11339151, Example 60	5-hydroxytryptamine receptor 7	Homo sapiens	 24.3								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555084&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			164065702	471695840							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170894	CCN(CCN1CCC(CC1)c1noc2cc(Cl)ccc12)S(=O)(=O)CCO	InChI=1S/C18H26ClN3O4S/c1-2-22(27(24,25)12-11-23)10-9-21-7-5-14(6-8-21)18-16-4-3-15(19)13-17(16)26-20-18/h3-4,13-14,23H,2,5-12H2,1H3	WKTMKMQREUNTCP-UHFFFAOYSA-N	555084	US11339151, Example 60	D(2) dopamine receptor	Homo sapiens	>1000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555084&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			164065702	471695840							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170895	CCN(CCN1CCC(CC1)c1noc2ccccc12)S(=O)(=O)CCO	InChI=1S/C18H27N3O4S/c1-2-21(26(23,24)14-13-22)12-11-20-9-7-15(8-10-20)18-16-5-3-4-6-17(16)25-19-18/h3-6,15,22H,2,7-14H2,1H3	OTKYJPDWHNDEEY-UHFFFAOYSA-N	555085	US11339151, Example 61	5-hydroxytryptamine receptor 2A	Human	 10.9								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555085&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552377	471695841							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170896	CCN(CCN1CCC(CC1)c1noc2ccccc12)S(=O)(=O)CCO	InChI=1S/C18H27N3O4S/c1-2-21(26(23,24)14-13-22)12-11-20-9-7-15(8-10-20)18-16-5-3-4-6-17(16)25-19-18/h3-6,15,22H,2,7-14H2,1H3	OTKYJPDWHNDEEY-UHFFFAOYSA-N	555085	US11339151, Example 61	5-hydroxytryptamine receptor 7	Homo sapiens	 12.7								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555085&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552377	471695841							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170897	CCN(CCN1CCC(CC1)c1noc2ccccc12)S(=O)(=O)CCO	InChI=1S/C18H27N3O4S/c1-2-21(26(23,24)14-13-22)12-11-20-9-7-15(8-10-20)18-16-5-3-4-6-17(16)25-19-18/h3-6,15,22H,2,7-14H2,1H3	OTKYJPDWHNDEEY-UHFFFAOYSA-N	555085	US11339151, Example 61	D(2) dopamine receptor	Homo sapiens	 514								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555085&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552377	471695841							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170898	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O3S/c1-2-23(27(25,26)12-11-24)10-9-22-7-5-15(6-8-22)18-14-21-19-13-16(20)3-4-17(18)19/h3-4,13-15,21,24H,2,5-12H2,1H3	WTXHTPKXUSMOPA-UHFFFAOYSA-N	555086	US11339151, Example 62	5-hydroxytryptamine receptor 2A	Human	 0.500								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555086&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552375	471695842							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170899	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O3S/c1-2-23(27(25,26)12-11-24)10-9-22-7-5-15(6-8-22)18-14-21-19-13-16(20)3-4-17(18)19/h3-4,13-15,21,24H,2,5-12H2,1H3	WTXHTPKXUSMOPA-UHFFFAOYSA-N	555086	US11339151, Example 62	5-hydroxytryptamine receptor 7	Homo sapiens	 2.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555086&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552375	471695842							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170900	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O3S/c1-2-23(27(25,26)12-11-24)10-9-22-7-5-15(6-8-22)18-14-21-19-13-16(20)3-4-17(18)19/h3-4,13-15,21,24H,2,5-12H2,1H3	WTXHTPKXUSMOPA-UHFFFAOYSA-N	555086	US11339151, Example 62	D(2) dopamine receptor	Homo sapiens	 104								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555086&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552375	471695842							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170901	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C18H27FN4O3S/c1-2-22(27(25,26)12-11-24)10-9-21-7-5-17(6-8-21)23-18-4-3-16(19)13-15(18)14-20-23/h3-4,13-14,17,24H,2,5-12H2,1H3	CABLYZHRIOWMRB-UHFFFAOYSA-N	555087	US11339151, Example 63	5-hydroxytryptamine receptor 2A	Human	 3.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555087&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552188	471695843							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170902	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C18H27FN4O3S/c1-2-22(27(25,26)12-11-24)10-9-21-7-5-17(6-8-21)23-18-4-3-16(19)13-15(18)14-20-23/h3-4,13-14,17,24H,2,5-12H2,1H3	CABLYZHRIOWMRB-UHFFFAOYSA-N	555087	US11339151, Example 63	5-hydroxytryptamine receptor 7	Homo sapiens	 6.90								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555087&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552188	471695843							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170903	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C18H27FN4O3S/c1-2-22(27(25,26)12-11-24)10-9-21-7-5-17(6-8-21)23-18-4-3-16(19)13-15(18)14-20-23/h3-4,13-14,17,24H,2,5-12H2,1H3	CABLYZHRIOWMRB-UHFFFAOYSA-N	555087	US11339151, Example 63	D(2) dopamine receptor	Homo sapiens	 532								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555087&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552188	471695843							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170904	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H29FN4O3S/c1-3-23(28(26,27)15(2)14-25)11-10-22-8-6-18(7-9-22)24-19-5-4-17(20)12-16(19)13-21-24/h4-5,12-13,15,18,25H,3,6-11,14H2,1-2H3	UXHXPQAQESSLQQ-UHFFFAOYSA-N	555088	US11339151, Example 64	5-hydroxytryptamine receptor 2A	Human	 1.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555088&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552226	471695844							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170905	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H29FN4O3S/c1-3-23(28(26,27)15(2)14-25)11-10-22-8-6-18(7-9-22)24-19-5-4-17(20)12-16(19)13-21-24/h4-5,12-13,15,18,25H,3,6-11,14H2,1-2H3	UXHXPQAQESSLQQ-UHFFFAOYSA-N	555088	US11339151, Example 64	5-hydroxytryptamine receptor 7	Homo sapiens	 2.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555088&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552226	471695844							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170906	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H29FN4O3S/c1-3-23(28(26,27)15(2)14-25)11-10-22-8-6-18(7-9-22)24-19-5-4-17(20)12-16(19)13-21-24/h4-5,12-13,15,18,25H,3,6-11,14H2,1-2H3	UXHXPQAQESSLQQ-UHFFFAOYSA-N	555088	US11339151, Example 64	D(2) dopamine receptor	Homo sapiens	 348								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555088&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552226	471695844							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170907	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)CN	InChI=1S/C19H29FN4O3/c1-2-24(19(26)16(25)12-21)10-9-23-7-5-13(6-8-23)18-15-4-3-14(20)11-17(15)27-22-18/h3-4,11,13,16,18,22,25H,2,5-10,12,21H2,1H3	GKZODULLMBHNRP-UHFFFAOYSA-N	555089	3-Amino-N-ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 65	5-hydroxytryptamine receptor 2A	Human	 4.00								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555089&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163585322	471695845							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170908	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)CN	InChI=1S/C19H29FN4O3/c1-2-24(19(26)16(25)12-21)10-9-23-7-5-13(6-8-23)18-15-4-3-14(20)11-17(15)27-22-18/h3-4,11,13,16,18,22,25H,2,5-10,12,21H2,1H3	GKZODULLMBHNRP-UHFFFAOYSA-N	555089	3-Amino-N-ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 65	5-hydroxytryptamine receptor 7	Homo sapiens	 7.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555089&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163585322	471695845							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170909	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)CN	InChI=1S/C19H29FN4O3/c1-2-24(19(26)16(25)12-21)10-9-23-7-5-13(6-8-23)18-15-4-3-14(20)11-17(15)27-22-18/h3-4,11,13,16,18,22,25H,2,5-10,12,21H2,1H3	GKZODULLMBHNRP-UHFFFAOYSA-N	555089	3-Amino-N-ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 65	D(2) dopamine receptor	Homo sapiens	 195								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555089&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163585322	471695845							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170910	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CNCC1O	InChI=1S/C21H29FN4O3/c1-2-26(21(28)17-12-23-13-18(17)27)10-9-25-7-5-14(6-8-25)20-16-4-3-15(22)11-19(16)29-24-20/h3-4,11,14,17-18,23,27H,2,5-10,12-13H2,1H3	XYGZFTTWYYTXOD-UHFFFAOYSA-N	555090	US11339151, Example 66	5-hydroxytryptamine receptor 2A	Human	 0.800								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555090&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552365	471695846							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170911	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CNCC1O	InChI=1S/C21H29FN4O3/c1-2-26(21(28)17-12-23-13-18(17)27)10-9-25-7-5-14(6-8-25)20-16-4-3-15(22)11-19(16)29-24-20/h3-4,11,14,17-18,23,27H,2,5-10,12-13H2,1H3	XYGZFTTWYYTXOD-UHFFFAOYSA-N	555090	US11339151, Example 66	5-hydroxytryptamine receptor 7	Homo sapiens	 5.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555090&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552365	471695846							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170912	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CNCC1O	InChI=1S/C21H29FN4O3/c1-2-26(21(28)17-12-23-13-18(17)27)10-9-25-7-5-14(6-8-25)20-16-4-3-15(22)11-19(16)29-24-20/h3-4,11,14,17-18,23,27H,2,5-10,12-13H2,1H3	XYGZFTTWYYTXOD-UHFFFAOYSA-N	555090	US11339151, Example 66	D(2) dopamine receptor	Homo sapiens	 212								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555090&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552365	471695846							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170913	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CNCCC1O	InChI=1S/C22H31FN4O3/c1-2-27(22(29)18-14-24-8-5-19(18)28)12-11-26-9-6-15(7-10-26)21-17-4-3-16(23)13-20(17)30-25-21/h3-4,13,15,18-19,24,28H,2,5-12,14H2,1H3	ZWSDZWGYYIXLJO-UHFFFAOYSA-N	555091	US11339151, Example 67	5-hydroxytryptamine receptor 2A	Human	 6.10								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555091&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552367	471695847							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170914	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CNCCC1O	InChI=1S/C22H31FN4O3/c1-2-27(22(29)18-14-24-8-5-19(18)28)12-11-26-9-6-15(7-10-26)21-17-4-3-16(23)13-20(17)30-25-21/h3-4,13,15,18-19,24,28H,2,5-12,14H2,1H3	ZWSDZWGYYIXLJO-UHFFFAOYSA-N	555091	US11339151, Example 67	5-hydroxytryptamine receptor 7	Homo sapiens	 0.900								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555091&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552367	471695847							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170915	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CNCCC1O	InChI=1S/C22H31FN4O3/c1-2-27(22(29)18-14-24-8-5-19(18)28)12-11-26-9-6-15(7-10-26)21-17-4-3-16(23)13-20(17)30-25-21/h3-4,13,15,18-19,24,28H,2,5-12,14H2,1H3	ZWSDZWGYYIXLJO-UHFFFAOYSA-N	555091	US11339151, Example 67	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555091&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552367	471695847							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170916	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H]1NCC[C@H]1O	InChI=1S/C21H29FN4O3/c1-2-26(21(28)20-17(27)5-8-23-20)12-11-25-9-6-14(7-10-25)19-16-4-3-15(22)13-18(16)29-24-19/h3-4,13-14,17,20,23,27H,2,5-12H2,1H3/t17-,20+/m1/s1	QRBKIEDIHQEIKP-XLIONFOSSA-N	555092	US11339151, Example 68	5-hydroxytryptamine receptor 2A	Human	 9.90								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555092&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552368	471695848							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170917	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H]1NCC[C@H]1O	InChI=1S/C21H29FN4O3/c1-2-26(21(28)20-17(27)5-8-23-20)12-11-25-9-6-14(7-10-25)19-16-4-3-15(22)13-18(16)29-24-19/h3-4,13-14,17,20,23,27H,2,5-12H2,1H3/t17-,20+/m1/s1	QRBKIEDIHQEIKP-XLIONFOSSA-N	555092	US11339151, Example 68	5-hydroxytryptamine receptor 7	Homo sapiens	 48.5								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555092&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552368	471695848							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170918	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H]1NCC[C@H]1O	InChI=1S/C21H29FN4O3/c1-2-26(21(28)20-17(27)5-8-23-20)12-11-25-9-6-14(7-10-25)19-16-4-3-15(22)13-18(16)29-24-19/h3-4,13-14,17,20,23,27H,2,5-12H2,1H3/t17-,20+/m1/s1	QRBKIEDIHQEIKP-XLIONFOSSA-N	555092	US11339151, Example 68	D(2) dopamine receptor	Homo sapiens	 910								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555092&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552368	471695848							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170919	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCCNC1	InChI=1S/C22H31FN4O3/c1-2-27(21(28)22(29)8-3-9-24-15-22)13-12-26-10-6-16(7-11-26)20-18-5-4-17(23)14-19(18)30-25-20/h4-5,14,16,24,29H,2-3,6-13,15H2,1H3	RRTOYKUQJIMLKS-UHFFFAOYSA-N	555093	US11339151, Example 69	5-hydroxytryptamine receptor 2A	Human	 0.600								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555093&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163941953	471695849							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170920	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCCNC1	InChI=1S/C22H31FN4O3/c1-2-27(21(28)22(29)8-3-9-24-15-22)13-12-26-10-6-16(7-11-26)20-18-5-4-17(23)14-19(18)30-25-20/h4-5,14,16,24,29H,2-3,6-13,15H2,1H3	RRTOYKUQJIMLKS-UHFFFAOYSA-N	555093	US11339151, Example 69	5-hydroxytryptamine receptor 7	Homo sapiens	 1.50								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555093&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163941953	471695849							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170921	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCCNC1	InChI=1S/C22H31FN4O3/c1-2-27(21(28)22(29)8-3-9-24-15-22)13-12-26-10-6-16(7-11-26)20-18-5-4-17(23)14-19(18)30-25-20/h4-5,14,16,24,29H,2-3,6-13,15H2,1H3	RRTOYKUQJIMLKS-UHFFFAOYSA-N	555093	US11339151, Example 69	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555093&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163941953	471695849							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170922	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCNC1	InChI=1S/C21H29FN4O3/c1-2-26(20(27)21(28)7-8-23-14-21)12-11-25-9-5-15(6-10-25)19-17-4-3-16(22)13-18(17)29-24-19/h3-4,13,15,23,28H,2,5-12,14H2,1H3	ZDNHZIBZTPDZKV-UHFFFAOYSA-N	555094	US11339151, Example 70	5-hydroxytryptamine receptor 2A	Human	 2.00								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555094&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156552366	471695850							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170923	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCNC1	InChI=1S/C21H29FN4O3/c1-2-26(20(27)21(28)7-8-23-14-21)12-11-25-9-5-15(6-10-25)19-17-4-3-16(22)13-18(17)29-24-19/h3-4,13,15,23,28H,2,5-12,14H2,1H3	ZDNHZIBZTPDZKV-UHFFFAOYSA-N	555094	US11339151, Example 70	5-hydroxytryptamine receptor 7	Homo sapiens	 3.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555094&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156552366	471695850							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170924	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCNC1	InChI=1S/C21H29FN4O3/c1-2-26(20(27)21(28)7-8-23-14-21)12-11-25-9-5-15(6-10-25)19-17-4-3-16(22)13-18(17)29-24-19/h3-4,13,15,23,28H,2,5-12,14H2,1H3	ZDNHZIBZTPDZKV-UHFFFAOYSA-N	555094	US11339151, Example 70	D(2) dopamine receptor	Homo sapiens	 52.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555094&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156552366	471695850							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170925	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)CNC(C)=O	InChI=1S/C21H31FN4O4/c1-3-26(21(29)18(28)13-23-14(2)27)11-10-25-8-6-15(7-9-25)20-17-5-4-16(22)12-19(17)30-24-20/h4-5,12,15,18,20,24,28H,3,6-11,13H2,1-2H3,(H,23,27)	YGQYHFNCAZNGCT-UHFFFAOYSA-N	555095	3-Acetamide-N-ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 71	5-hydroxytryptamine receptor 2A	Human	 2.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555095&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			164122338	471695851							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170926	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)CNC(C)=O	InChI=1S/C21H31FN4O4/c1-3-26(21(29)18(28)13-23-14(2)27)11-10-25-8-6-15(7-9-25)20-17-5-4-16(22)12-19(17)30-24-20/h4-5,12,15,18,20,24,28H,3,6-11,13H2,1-2H3,(H,23,27)	YGQYHFNCAZNGCT-UHFFFAOYSA-N	555095	3-Acetamide-N-ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 71	5-hydroxytryptamine receptor 7	Homo sapiens	 6.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555095&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			164122338	471695851							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170927	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)CNC(C)=O	InChI=1S/C21H31FN4O4/c1-3-26(21(29)18(28)13-23-14(2)27)11-10-25-8-6-15(7-9-25)20-17-5-4-16(22)12-19(17)30-24-20/h4-5,12,15,18,20,24,28H,3,6-11,13H2,1-2H3,(H,23,27)	YGQYHFNCAZNGCT-UHFFFAOYSA-N	555095	3-Acetamide-N-ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 71	D(2) dopamine receptor	Homo sapiens	 223								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555095&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			164122338	471695851							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170928	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCCN(C1)C(C)=O	InChI=1S/C24H33FN4O4/c1-3-28(23(31)24(32)9-4-10-29(16-24)17(2)30)14-13-27-11-7-18(8-12-27)22-20-6-5-19(25)15-21(20)33-26-22/h5-6,15,18,32H,3-4,7-14,16H2,1-2H3	BTICABKVLJBOCS-UHFFFAOYSA-N	555096	US11339151, Example 72	5-hydroxytryptamine receptor 2A	Human	 1.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555096&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163466827	471695852							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170929	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCCN(C1)C(C)=O	InChI=1S/C24H33FN4O4/c1-3-28(23(31)24(32)9-4-10-29(16-24)17(2)30)14-13-27-11-7-18(8-12-27)22-20-6-5-19(25)15-21(20)33-26-22/h5-6,15,18,32H,3-4,7-14,16H2,1-2H3	BTICABKVLJBOCS-UHFFFAOYSA-N	555096	US11339151, Example 72	5-hydroxytryptamine receptor 7	Homo sapiens	 10.6								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555096&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163466827	471695852							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170930	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCCN(C1)C(C)=O	InChI=1S/C24H33FN4O4/c1-3-28(23(31)24(32)9-4-10-29(16-24)17(2)30)14-13-27-11-7-18(8-12-27)22-20-6-5-19(25)15-21(20)33-26-22/h5-6,15,18,32H,3-4,7-14,16H2,1-2H3	BTICABKVLJBOCS-UHFFFAOYSA-N	555096	US11339151, Example 72	D(2) dopamine receptor	Homo sapiens	<100.0								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555096&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163466827	471695852							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170931	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(CC1O)C(C)=O	InChI=1S/C23H31FN4O4/c1-3-27(23(31)19-13-28(15(2)29)14-20(19)30)11-10-26-8-6-16(7-9-26)22-18-5-4-17(24)12-21(18)32-25-22/h4-5,12,16,19-20,30H,3,6-11,13-14H2,1-2H3	ZPWUNRZLLFCXQR-UHFFFAOYSA-N	555097	US11339151, Example 73	5-hydroxytryptamine receptor 2A	Human	 5.70								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555097&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			164164521	471695853							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170932	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(CC1O)C(C)=O	InChI=1S/C23H31FN4O4/c1-3-27(23(31)19-13-28(15(2)29)14-20(19)30)11-10-26-8-6-16(7-9-26)22-18-5-4-17(24)12-21(18)32-25-22/h4-5,12,16,19-20,30H,3,6-11,13-14H2,1-2H3	ZPWUNRZLLFCXQR-UHFFFAOYSA-N	555097	US11339151, Example 73	5-hydroxytryptamine receptor 7	Homo sapiens	 14.4								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555097&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			164164521	471695853							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170933	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(CC1O)C(C)=O	InChI=1S/C23H31FN4O4/c1-3-27(23(31)19-13-28(15(2)29)14-20(19)30)11-10-26-8-6-16(7-9-26)22-18-5-4-17(24)12-21(18)32-25-22/h4-5,12,16,19-20,30H,3,6-11,13-14H2,1-2H3	ZPWUNRZLLFCXQR-UHFFFAOYSA-N	555097	US11339151, Example 73	D(2) dopamine receptor	Homo sapiens	 205								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555097&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			164164521	471695853							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170934	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(CCC1O)C(C)=O	InChI=1S/C24H33FN4O4/c1-3-28(24(32)20-15-29(16(2)30)11-8-21(20)31)13-12-27-9-6-17(7-10-27)23-19-5-4-18(25)14-22(19)33-26-23/h4-5,14,17,20-21,31H,3,6-13,15H2,1-2H3	OBQQHIJXDBDJLM-UHFFFAOYSA-N	555098	US11339151, Example 74	5-hydroxytryptamine receptor 2A	Human	 2.40								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555098&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			163828529	471695854							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170935	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(CCC1O)C(C)=O	InChI=1S/C24H33FN4O4/c1-3-28(24(32)20-15-29(16(2)30)11-8-21(20)31)13-12-27-9-6-17(7-10-27)23-19-5-4-18(25)14-22(19)33-26-23/h4-5,14,17,20-21,31H,3,6-13,15H2,1-2H3	OBQQHIJXDBDJLM-UHFFFAOYSA-N	555098	US11339151, Example 74	5-hydroxytryptamine receptor 7	Homo sapiens	 6.80								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555098&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			163828529	471695854							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170936	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(CCC1O)C(C)=O	InChI=1S/C24H33FN4O4/c1-3-28(24(32)20-15-29(16(2)30)11-8-21(20)31)13-12-27-9-6-17(7-10-27)23-19-5-4-18(25)14-22(19)33-26-23/h4-5,14,17,20-21,31H,3,6-13,15H2,1-2H3	OBQQHIJXDBDJLM-UHFFFAOYSA-N	555098	US11339151, Example 74	D(2) dopamine receptor	Homo sapiens	 138								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555098&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			163828529	471695854							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170937	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(C)CC1O	InChI=1S/C22H31FN4O3/c1-3-27(22(29)18-13-25(2)14-19(18)28)11-10-26-8-6-15(7-9-26)21-17-5-4-16(23)12-20(17)30-24-21/h4-5,12,15,18-19,28H,3,6-11,13-14H2,1-2H3	SMYXZGAHTSUBQF-UHFFFAOYSA-N	555099	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-4-hydroxy-1-methylpyrrolidine-3-carboxamide::US11339151, Example 75	5-hydroxytryptamine receptor 2A	Human	 1.000								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555099&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540509	471695855							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170938	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(C)CC1O	InChI=1S/C22H31FN4O3/c1-3-27(22(29)18-13-25(2)14-19(18)28)11-10-26-8-6-15(7-9-26)21-17-5-4-16(23)12-20(17)30-24-21/h4-5,12,15,18-19,28H,3,6-11,13-14H2,1-2H3	SMYXZGAHTSUBQF-UHFFFAOYSA-N	555099	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-4-hydroxy-1-methylpyrrolidine-3-carboxamide::US11339151, Example 75	5-hydroxytryptamine receptor 7	Homo sapiens	 3.60								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555099&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540509	471695855							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170939	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(C)CC1O	InChI=1S/C22H31FN4O3/c1-3-27(22(29)18-13-25(2)14-19(18)28)11-10-26-8-6-15(7-9-26)21-17-5-4-16(23)12-20(17)30-24-21/h4-5,12,15,18-19,28H,3,6-11,13-14H2,1-2H3	SMYXZGAHTSUBQF-UHFFFAOYSA-N	555099	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-4-hydroxy-1-methylpyrrolidine-3-carboxamide::US11339151, Example 75	D(2) dopamine receptor	Homo sapiens	 124								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555099&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540509	471695855							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170940	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(C)CCC1O	InChI=1S/C23H33FN4O3/c1-3-28(23(30)19-15-26(2)9-8-20(19)29)13-12-27-10-6-16(7-11-27)22-18-5-4-17(24)14-21(18)31-25-22/h4-5,14,16,19-20,29H,3,6-13,15H2,1-2H3	ZQNZTVPOPCUPTB-UHFFFAOYSA-N	555100	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-4-hydroxy-1-methylpiperidine-3-carboxamide::US11339151, Example 76	5-hydroxytryptamine receptor 2A	Human	 7.20								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555100&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search			156540519	471695856							1	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV	6WHA,7RAN	5-hydroxytryptamine receptor 2A	5HT2A_HUMAN	P28223	B2RAC5 B4DZ79 F5GWE8 Q5T8C0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170941	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(C)CCC1O	InChI=1S/C23H33FN4O3/c1-3-28(23(30)19-15-26(2)9-8-20(19)29)13-12-27-10-6-16(7-11-27)22-18-5-4-17(24)14-21(18)31-25-22/h4-5,14,16,19-20,29H,3,6-13,15H2,1-2H3	ZQNZTVPOPCUPTB-UHFFFAOYSA-N	555100	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-4-hydroxy-1-methylpiperidine-3-carboxamide::US11339151, Example 76	5-hydroxytryptamine receptor 7	Homo sapiens	 14.4								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555100&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search			156540519	471695856							1	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD	7XTC	5-hydroxytryptamine receptor 7	5HT7R_HUMAN	P34969	B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170942	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(C)CCC1O	InChI=1S/C23H33FN4O3/c1-3-28(23(30)19-15-26(2)9-8-20(19)29)13-12-27-10-6-16(7-11-27)22-18-5-4-17(24)14-21(18)31-25-22/h4-5,14,16,19-20,29H,3,6-13,15H2,1-2H3	ZQNZTVPOPCUPTB-UHFFFAOYSA-N	555100	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-4-hydroxy-1-methylpiperidine-3-carboxamide::US11339151, Example 76	D(2) dopamine receptor	Homo sapiens	 193								US Patent		10.7270/Q2N019Q1		aid1806551	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555100&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			156540519	471695856							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1170943	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m1/s1	FDLRDRBESBJAAV-CYBMUJFWSA-N	555025	(2R)—N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 1	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4800							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555025&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540522	471695782							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170944	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)CCO	InChI=1S/C19H27FN4O2/c1-2-23(19(26)7-12-25)11-10-22-8-5-17(6-9-22)24-18-4-3-16(20)13-15(18)14-21-24/h3-4,13-14,17,25H,2,5-12H2,1H3	YPTQUGODRIZPOA-UHFFFAOYSA-N	555026	N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-3-hydroxypropanamide::US11339151, Example 2	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 7400							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555026&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540526	471695783							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170945	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C19H27FN4O2/c1-3-23(19(26)14(2)25)11-10-22-8-6-17(7-9-22)24-18-5-4-16(20)12-15(18)13-21-24/h4-5,12-14,17,25H,3,6-11H2,1-2H3/t14-/m1/s1	HJURXLMWJCKIJE-CQSZACIVSA-N	555027	(2R)—N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 3	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555027&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540503	471695784							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170946	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3	FDLRDRBESBJAAV-UHFFFAOYSA-N	555028	US11339151, Example 4::US11339151, Example 40	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 7100							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555028&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540501	471695785							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170947	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)CCC(=O)OC	InChI=1S/C22H30FN3O5/c1-3-26(22(29)18(27)6-7-20(28)30-2)13-12-25-10-8-15(9-11-25)21-17-5-4-16(23)14-19(17)31-24-21/h4-5,14-15,18,27H,3,6-13H2,1-2H3	ULFZVKKURLBXLU-UHFFFAOYSA-N	555029	US11339151, Example 5	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 1100							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555029&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552395	471695786							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170948	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)(C)O	InChI=1S/C20H28FN3O3/c1-4-24(19(25)20(2,3)26)12-11-23-9-7-14(8-10-23)18-16-6-5-15(21)13-17(16)27-22-18/h5-6,13-14,26H,4,7-12H2,1-3H3	KKHDVTQDKZDTLG-UHFFFAOYSA-N	555030	US11339151, Example 6	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 1500							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555030&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552398	471695787							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170949	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)(C)CO	InChI=1S/C21H30FN3O3/c1-4-25(20(27)21(2,3)14-26)12-11-24-9-7-15(8-10-24)19-17-6-5-16(22)13-18(17)28-23-19/h5-6,13,15,26H,4,7-12,14H2,1-3H3	VUIPRPLRHSZXDX-UHFFFAOYSA-N	555031	US11339151, Example 7	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 3500							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555031&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552393	471695788							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170950	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C(C)C	InChI=1S/C21H30FN3O3/c1-4-25(21(27)20(26)14(2)3)12-11-24-9-7-15(8-10-24)19-17-6-5-16(22)13-18(17)28-23-19/h5-6,13-15,20,26H,4,7-12H2,1-3H3	GFMBUKFDHKZBGH-UHFFFAOYSA-N	555032	US11339151, Example 8	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4200							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555032&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552397	471695789							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170951	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CCC(O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3	VXWNWYXXDJFKLS-UHFFFAOYSA-N	555033	US11339151, Example 9	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 5400							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555033&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695790							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170952	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CC(C)O	InChI=1S/C20H28FN3O3/c1-3-24(19(26)12-14(2)25)11-10-23-8-6-15(7-9-23)20-17-5-4-16(21)13-18(17)27-22-20/h4-5,13-15,25H,3,6-12H2,1-2H3	ADHQMOBSCUKLBQ-UHFFFAOYSA-N	555034	US11339151, Example 10	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 3600							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555034&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552394	471695791							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170953	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCOCC1	InChI=1S/C22H30FN3O4/c1-2-26(21(27)22(28)7-13-29-14-8-22)12-11-25-9-5-16(6-10-25)20-18-4-3-17(23)15-19(18)30-24-20/h3-4,15-16,28H,2,5-14H2,1H3	MWUUTPCYIHCLOP-UHFFFAOYSA-N	555035	US11339151, Example 11	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 10500							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555035&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163791103	471695792							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170954	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CO	InChI=1S/C18H24FN3O3/c1-2-22(17(24)12-23)10-9-21-7-5-13(6-8-21)18-15-4-3-14(19)11-16(15)25-20-18/h3-4,11,13,23H,2,5-10,12H2,1H3	JYAPUSNOOULIIG-UHFFFAOYSA-N	555036	US11339151, Example 12	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2200							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555036&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552386	471695793							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170955	CCN(CCN1CCC(CC1)c1noc2cc(F)c(C)cc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-4-24(20(26)14(3)25)10-9-23-7-5-15(6-8-23)19-16-11-13(2)17(21)12-18(16)27-22-19/h11-12,14-15,25H,4-10H2,1-3H3/t14-/m0/s1	AUXKYMACGZAJNK-AWEZNQCLSA-N	555037	US11339151, Example 13	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2900							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555037&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552385	471695794							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170956	CCN(CCN1CCC(CC1)c1noc2ccc(C)cc12)C(=O)[C@H](C)O	InChI=1S/C20H29N3O3/c1-4-23(20(25)15(3)24)12-11-22-9-7-16(8-10-22)19-17-13-14(2)5-6-18(17)26-21-19/h5-6,13,15-16,24H,4,7-12H2,1-3H3/t15-/m0/s1	IYCHAMBXIBWQLQ-HNNXBMFYSA-N	555038	US11339151, Example 14	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 9600							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555038&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552387	471695795							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170957	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	FDLRDRBESBJAAV-ZDUSSCGKSA-N	555040	(2S)—N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 16	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4800							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555040&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540500	471695797							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170958	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CCO	InChI=1S/C19H26FN3O3/c1-2-23(18(25)7-12-24)11-10-22-8-5-14(6-9-22)19-16-4-3-15(20)13-17(16)26-21-19/h3-4,13-14,24H,2,5-12H2,1H3	APSSHASNQVGROU-UHFFFAOYSA-N	555041	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-3-hydroxypropanamide::US11339151, Example 17	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2800							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555041&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540499	471695798							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170959	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)COC	InChI=1S/C20H30FN3O4/c1-3-24(20(26)17(25)13-27-2)11-10-23-8-6-14(7-9-23)19-16-5-4-15(21)12-18(16)28-22-19/h4-5,12,14,17,19,22,25H,3,6-11,13H2,1-2H3	DEINYMBGVCCVJR-UHFFFAOYSA-N	555042	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxy-3-methoxypropanamide::US11339151, Example 18	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4100							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555042&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163513052	471695799							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170960	CCN(CCN1CCC(CC1)c1n[nH]c2cc(F)ccc12)C(=O)C(C)O			555043	N-Ethyl-N-{2-[4-(6-fluoro-1H-indazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 19	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555043&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540514	471695800							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170961	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)C(=O)[C@H](C)O			555044	(2S)—N-Ethyl-N-{2-[4-(6-fluoro-1H-indol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 20	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4200							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555044&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540505	471695801							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170962	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C19H27FN4O2/c1-3-23(19(26)14(2)25)11-10-22-8-6-17(7-9-22)24-18-5-4-16(20)12-15(18)13-21-24/h4-5,12-14,17,25H,3,6-11H2,1-2H3/t14-/m0/s1	HJURXLMWJCKIJE-AWEZNQCLSA-N	555045	(2S)—N-Ethyl-N-{2-[4-(5-fluoro-1H-indazol-1-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 21	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 15300							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555045&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540516	471695802							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170963	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)C(C)O			555046	N-Ethyl-2-hydroxy-N-{2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl}propanamide::US11339151, Example 22	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555046&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552189	471695803							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170964	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)[C@H](C)O			555047	(2S)—N-Ethyl-2-hydroxy-N-{2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl}propanamide::US11339151, Example 23	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555047&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552404	471695804							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170965	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CC1	InChI=1S/C20H26FN3O3/c1-2-24(19(25)20(26)7-8-20)12-11-23-9-5-14(6-10-23)18-16-4-3-15(21)13-17(16)27-22-18/h3-4,13-14,26H,2,5-12H2,1H3	PYMPKOMERHZEEW-UHFFFAOYSA-N	555048	US11339151, Example 24	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 5500							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555048&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163887300	471695805							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170966	CCN(CCN1CCC(CC1)c1noc2ccccc12)C(=O)C(C)O	InChI=1S/C19H27N3O3/c1-3-22(19(24)14(2)23)13-12-21-10-8-15(9-11-21)18-16-6-4-5-7-17(16)25-20-18/h4-7,14-15,23H,3,8-13H2,1-2H3	VGYBISULYWZAPR-UHFFFAOYSA-N	555049	US11339151, Example 25	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555049&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			164029881	471695806							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170967	CCN(CCN1CCN(CC1)c1noc2ccccc12)C(=O)C(C)O	InChI=1S/C18H26N4O3/c1-3-21(18(24)14(2)23)11-8-20-9-12-22(13-10-20)17-15-6-4-5-7-16(15)25-19-17/h4-7,14,23H,3,8-13H2,1-2H3	TUJFSEGSSALVST-UHFFFAOYSA-N	555050	US11339151, Example 26	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555050&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163983570	471695807							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170968	CCN(CCN1CCN(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C18H25FN4O3/c1-3-22(18(25)13(2)24)9-6-21-7-10-23(11-8-21)17-15-5-4-14(19)12-16(15)26-20-17/h4-5,12-13,24H,3,6-11H2,1-2H3	XJNRZWHOAMPWIC-UHFFFAOYSA-N	555051	US11339151, Example 27	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555051&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			164095080	471695808							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170969	CC[C@@H](O)C(=O)N(CC)CCN1CCC(CC1)c1noc2cc(F)ccc12	InChI=1S/C20H28FN3O3/c1-3-17(25)20(26)24(4-2)12-11-23-9-7-14(8-10-23)19-16-6-5-15(21)13-18(16)27-22-19/h5-6,13-14,17,25H,3-4,7-12H2,1-2H3/t17-/m1/s1	BDJQYVCQQJQNCR-QGZVFWFLSA-N	555053	US11339151, Example 29	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 900							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555053&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163447038	471695810							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170970	CC(O)C(=O)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)CC1CC1	InChI=1S/C21H28FN3O3/c1-14(26)21(27)25(13-15-2-3-15)11-10-24-8-6-16(7-9-24)20-18-5-4-17(22)12-19(18)28-23-20/h4-5,12,14-16,26H,2-3,6-11,13H2,1H3	SGPHWUNCTMLCQF-UHFFFAOYSA-N	555054	US11339151, Example 30	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 1200							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555054&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552382	471695811							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170971	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3	ASBHLQBMEPLWID-UHFFFAOYSA-N	555055	US11339151, Example 31	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 3100							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555055&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163432943	471695812							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170972	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CCCCC1O	InChI=1S/C23H32FN3O3/c1-2-27(23(29)18-5-3-4-6-20(18)28)14-13-26-11-9-16(10-12-26)22-19-8-7-17(24)15-21(19)30-25-22/h7-8,15-16,18,20,28H,2-6,9-14H2,1H3	CJCHZXCLUYLXJM-UHFFFAOYSA-N	555057	US11339151, Example 33	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2200							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555057&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163486634	471695814							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170973	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(O)C(F)(F)F	InChI=1S/C19H23F4N3O3/c1-2-26(18(28)17(27)19(21,22)23)10-9-25-7-5-12(6-8-25)16-14-4-3-13(20)11-15(14)29-24-16/h3-4,11-12,17,27H,2,5-10H2,1H3	VJYQMOSNEVQNJR-UHFFFAOYSA-N	555058	US11339151, Example 34	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 7300							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555058&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552380	471695815							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170974	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)CCO	InChI=1S/C20H28FN3O3/c1-14(2)24(19(26)7-12-25)11-10-23-8-5-15(6-9-23)20-17-4-3-16(21)13-18(17)27-22-20/h3-4,13-15,25H,5-12H2,1-2H3	YQCPDRVHUVCVIN-UHFFFAOYSA-N	555059	US11339151, Example 35	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4300							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555059&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552384	471695816							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170975	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(F)(F)CO	InChI=1S/C19H24F3N3O3/c1-2-25(18(27)19(21,22)12-26)10-9-24-7-5-13(6-8-24)17-15-4-3-14(20)11-16(15)28-23-17/h3-4,11,13,26H,2,5-10,12H2,1H3	BCPXPZBIZDMKQR-UHFFFAOYSA-N	555060	US11339151, Example 36	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 1300							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555060&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163446060	471695817							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170976	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)CO	InChI=1S/C20H28FN3O3/c1-3-24(20(26)14(2)13-25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12,14-15,25H,3,6-11,13H2,1-2H3	FJSMDTWYILVAAN-UHFFFAOYSA-N	555061	US11339151, Example 37	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555061&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163551813	471695818							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170977	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-3-24(20(26)14(2)25)10-4-9-23-11-7-15(8-12-23)19-17-6-5-16(21)13-18(17)27-22-19/h5-6,13-15,25H,3-4,7-12H2,1-2H3/t14-/m0/s1	PJWKDVIAVIYPPN-AWEZNQCLSA-N	555062	US11339151, Example 38	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555062&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163869882	471695819							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170978	CCCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O3/c1-3-8-24(20(26)14(2)25)12-11-23-9-6-15(7-10-23)19-17-5-4-16(21)13-18(17)27-22-19/h4-5,13-15,25H,3,6-12H2,1-2H3	IDBDRTSGQKZOSY-UHFFFAOYSA-N	555063	US11339151, Example 39	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4700							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555063&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163639561	471695820							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170979	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-5-4-15(20)12-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3	FDLRDRBESBJAAV-UHFFFAOYSA-N	555028	US11339151, Example 4::US11339151, Example 40	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 9900							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555028&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540501	471695785							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170980	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H](C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3/t14-/m0/s1	ASBHLQBMEPLWID-AWEZNQCLSA-N	555065	US11339151, Example 41	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 6700							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555065&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163432941	471695821							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170981	CC(C)N(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H](C)O	InChI=1S/C20H28FN3O3/c1-13(2)24(20(26)14(3)25)11-10-23-8-6-15(7-9-23)19-17-5-4-16(21)12-18(17)27-22-19/h4-5,12-15,25H,6-11H2,1-3H3/t14-/m1/s1	ASBHLQBMEPLWID-CQSZACIVSA-N	555066	US11339151, Example 42	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 6400							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555066&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163432942	471695822							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170982	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@H]1CC[C@H](O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3/t17-,19-	VXWNWYXXDJFKLS-UAPYVXQJSA-N	555067	US11339151, Example 43	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 7000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555067&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695823							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170983	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)[C@@H]1CC[C@H](O)CC1	InChI=1S/C23H32FN3O3/c1-2-27(23(29)17-3-6-19(28)7-4-17)14-13-26-11-9-16(10-12-26)22-20-8-5-18(24)15-21(20)30-25-22/h5,8,15-17,19,28H,2-4,6-7,9-14H2,1H3/t17-,19+	VXWNWYXXDJFKLS-IZAXUBKRSA-N	555068	US11339151, Example 44	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 6400							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555068&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552396	471695824							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170984	CCN(CCN1CCC(CC1)c1noc2ccc(F)cc12)C(=O)[C@H](C)O	InChI=1S/C19H26FN3O3/c1-3-23(19(25)13(2)24)11-10-22-8-6-14(7-9-22)18-16-12-15(20)4-5-17(16)26-21-18/h4-5,12-14,24H,3,6-11H2,1-2H3/t13-/m0/s1	OCFYVNCLSBVCRR-ZDUSSCGKSA-N	555069	US11339151, Example 45	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555069&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163829252	471695825							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170985	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CC(O)C1	InChI=1S/C21H28FN3O3/c1-2-25(21(27)15-11-17(26)12-15)10-9-24-7-5-14(6-8-24)20-18-4-3-16(22)13-19(18)28-23-20/h3-4,13-15,17,26H,2,5-12H2,1H3	TVUOUHQBOXWHNG-UHFFFAOYSA-N	555070	US11339151, Example 46	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 5700							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555070&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163985344	471695826							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170986	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)CCO	InChI=1S/C20H29N3O2/c1-2-23(20(25)9-14-24)13-12-22-10-7-16(8-11-22)18-15-21-19-6-4-3-5-17(18)19/h3-6,15-16,21,24H,2,7-14H2,1H3	WJBOFUDAMNIJRL-UHFFFAOYSA-N	555071	US11339151, Example 47	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 5400							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555071&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552504	471695827							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170987	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)C(=O)CCO	InChI=1S/C20H28FN3O2/c1-2-24(20(26)7-12-25)11-10-23-8-5-15(6-9-23)18-14-22-19-13-16(21)3-4-17(18)19/h3-4,13-15,22,25H,2,5-12H2,1H3	KAAGJIUPRMXDTG-UHFFFAOYSA-N	555072	US11339151, Example 48	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2900							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555072&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163699809	471695828							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170988	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)C(=O)[C@@H](C)O			555073	US11339151, Example 49	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555073&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163486284	471695829							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170989	CCN(CCN1CCC(CC1)n1ccc2cc(F)ccc12)C(=O)C(C)O	InChI=1S/C20H28FN3O2/c1-3-23(20(26)15(2)25)13-12-22-9-7-18(8-10-22)24-11-6-16-14-17(21)4-5-19(16)24/h4-6,11,14-15,18,25H,3,7-10,12-13H2,1-2H3	CJXRRILKADPIQO-UHFFFAOYSA-N	555074	US11339151, Example 50	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 6200							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555074&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163487669	471695830							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170990	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C18H26FN3O4S/c1-2-22(27(24,25)12-11-23)10-9-21-7-5-14(6-8-21)18-16-4-3-15(19)13-17(16)26-20-18/h3-4,13-14,23H,2,5-12H2,1H3	LAUGNMXDAVIKFQ-UHFFFAOYSA-N	555075	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxyethane-1-sulfonamide::US11339151, Example 51	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 6900							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555075&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540520	471695831							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170991	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O4S/c1-2-23(28(25,26)13-12-24)9-3-8-22-10-6-15(7-11-22)19-17-5-4-16(20)14-18(17)27-21-19/h4-5,14-15,24H,2-3,6-13H2,1H3	CCDSAGIQOBMXST-UHFFFAOYSA-N	555077	US11339151, Example 53	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 7200							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555077&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552225	471695833							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170992	CCN(CCCN1CCC(CC1)c1noc2ccccc12)S(=O)(=O)C(C)CO	InChI=1S/C20H31N3O4S/c1-3-23(28(25,26)16(2)15-24)12-6-11-22-13-9-17(10-14-22)20-18-7-4-5-8-19(18)27-21-20/h4-5,7-8,16-17,24H,3,6,9-15H2,1-2H3	VANOULQUECNACR-UHFFFAOYSA-N	555078	US11339151, Example 54	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 7400							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555078&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			164022293	471695834							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170993	CCN(CCCN1CCN(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H29FN4O4S/c1-3-24(29(26,27)15(2)14-25)8-4-7-22-9-11-23(12-10-22)19-17-6-5-16(20)13-18(17)28-21-19/h5-6,13,15,25H,3-4,7-12,14H2,1-2H3	UCUKBRIYXZZGPO-UHFFFAOYSA-N	555079	US11339151, Example 55	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 7400							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555079&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163993670	471695835							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170994	CCN(CCCN1CCC(CC1)c1noc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C20H30FN3O4S/c1-3-24(29(26,27)15(2)14-25)10-4-9-23-11-7-16(8-12-23)20-18-6-5-17(21)13-19(18)28-22-20/h5-6,13,15-16,25H,3-4,7-12,14H2,1-2H3	QBAFYRJKNUYHMO-UHFFFAOYSA-N	555080	US11339151, Example 56	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2100							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555080	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555080&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163890379	471695836							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170995	CCN(CCN1CCC(CC1)c1c[nH]c2ccccc12)S(=O)(=O)CCO	InChI=1S/C19H29N3O3S/c1-2-22(26(24,25)14-13-23)12-11-21-9-7-16(8-10-21)18-15-20-19-6-4-3-5-17(18)19/h3-6,15-16,20,23H,2,7-14H2,1H3	VLXOYOJCCCNIRP-UHFFFAOYSA-N	555081	US11339151, Example 57	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 6200							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555081&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			164035772	471695837							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170996	CCN(CCN1CCC(CC1)c1noc2cc(F)c(C)cc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O4S/c1-3-23(28(25,26)11-10-24)9-8-22-6-4-15(5-7-22)19-16-12-14(2)17(20)13-18(16)27-21-19/h12-13,15,24H,3-11H2,1-2H3	RZMZSGLGLBSHEO-UHFFFAOYSA-N	555082	US11339151, Example 58	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555082&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552373	471695838							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170997	CCN(CCN1CCC(CC1)c1noc2ccc(C)cc12)S(=O)(=O)CCO	InChI=1S/C19H29N3O4S/c1-3-22(27(24,25)13-12-23)11-10-21-8-6-16(7-9-21)19-17-14-15(2)4-5-18(17)26-20-19/h4-5,14,16,23H,3,6-13H2,1-2H3	DMCYGCVJPSDQON-UHFFFAOYSA-N	555083	US11339151, Example 59	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555083&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552374	471695839							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170998	CCN(CCN1CCC(CC1)c1noc2ccccc12)S(=O)(=O)CCO	InChI=1S/C18H27N3O4S/c1-2-21(26(23,24)14-13-22)12-11-20-9-7-15(8-10-20)18-16-5-3-4-6-17(16)25-19-18/h3-6,15,22H,2,7-14H2,1H3	OTKYJPDWHNDEEY-UHFFFAOYSA-N	555085	US11339151, Example 61	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555085&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552377	471695841							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1170999	CCN(CCN1CCC(CC1)c1c[nH]c2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C19H28FN3O3S/c1-2-23(27(25,26)12-11-24)10-9-22-7-5-15(6-8-22)18-14-21-19-13-16(20)3-4-17(18)19/h3-4,13-15,21,24H,2,5-12H2,1H3	WTXHTPKXUSMOPA-UHFFFAOYSA-N	555086	US11339151, Example 62	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 5400							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555086&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552375	471695842							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171000	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)S(=O)(=O)CCO	InChI=1S/C18H27FN4O3S/c1-2-22(27(25,26)12-11-24)10-9-21-7-5-17(6-8-21)23-18-4-3-16(19)13-15(18)14-20-23/h3-4,13-14,17,24H,2,5-12H2,1H3	CABLYZHRIOWMRB-UHFFFAOYSA-N	555087	US11339151, Example 63	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 14500							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555087&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552188	471695843							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171001	CCN(CCN1CCC(CC1)n1ncc2cc(F)ccc12)S(=O)(=O)C(C)CO	InChI=1S/C19H29FN4O3S/c1-3-23(28(26,27)15(2)14-25)11-10-22-8-6-18(7-9-22)24-19-5-4-17(20)12-16(19)13-21-24/h4-5,12-13,15,18,25H,3,6-11,14H2,1-2H3	UXHXPQAQESSLQQ-UHFFFAOYSA-N	555088	US11339151, Example 64	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555088&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552226	471695844							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171002	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)CN	InChI=1S/C19H29FN4O3/c1-2-24(19(26)16(25)12-21)10-9-23-7-5-13(6-8-23)18-15-4-3-14(20)11-17(15)27-22-18/h3-4,11,13,16,18,22,25H,2,5-10,12,21H2,1H3	GKZODULLMBHNRP-UHFFFAOYSA-N	555089	3-Amino-N-ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 65	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555089&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163585322	471695845							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171003	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CNCC1O	InChI=1S/C21H29FN4O3/c1-2-26(21(28)17-12-23-13-18(17)27)10-9-25-7-5-14(6-8-25)20-16-4-3-15(22)11-19(16)29-24-20/h3-4,11,14,17-18,23,27H,2,5-10,12-13H2,1H3	XYGZFTTWYYTXOD-UHFFFAOYSA-N	555090	US11339151, Example 66	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555090&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552365	471695846							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171004	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CNCCC1O	InChI=1S/C22H31FN4O3/c1-2-27(22(29)18-14-24-8-5-19(18)28)12-11-26-9-6-15(7-10-26)21-17-4-3-16(23)13-20(17)30-25-21/h3-4,13,15,18-19,24,28H,2,5-12,14H2,1H3	ZWSDZWGYYIXLJO-UHFFFAOYSA-N	555091	US11339151, Example 67	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555091&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552367	471695847							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171005	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCCNC1	InChI=1S/C22H31FN4O3/c1-2-27(21(28)22(29)8-3-9-24-15-22)13-12-26-10-6-16(7-11-26)20-18-5-4-17(23)14-19(18)30-25-20/h4-5,14,16,24,29H,2-3,6-13,15H2,1H3	RRTOYKUQJIMLKS-UHFFFAOYSA-N	555093	US11339151, Example 69	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555093&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163941953	471695849							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171006	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCNC1	InChI=1S/C21H29FN4O3/c1-2-26(20(27)21(28)7-8-23-14-21)12-11-25-9-5-15(6-10-25)19-17-4-3-16(22)13-18(17)29-24-19/h3-4,13,15,23,28H,2,5-12,14H2,1H3	ZDNHZIBZTPDZKV-UHFFFAOYSA-N	555094	US11339151, Example 70	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555094&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156552366	471695850							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171007	CCN(CCN1CCC(CC1)C1NOc2cc(F)ccc12)C(=O)C(O)CNC(C)=O	InChI=1S/C21H31FN4O4/c1-3-26(21(29)18(28)13-23-14(2)27)11-10-25-8-6-15(7-9-25)20-17-5-4-16(22)12-19(17)30-24-20/h4-5,12,15,18,20,24,28H,3,6-11,13H2,1-2H3,(H,23,27)	YGQYHFNCAZNGCT-UHFFFAOYSA-N	555095	3-Acetamide-N-ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-2-hydroxypropanamide::US11339151, Example 71	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555095&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			164122338	471695851							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171008	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1(O)CCCN(C1)C(C)=O	InChI=1S/C24H33FN4O4/c1-3-28(23(31)24(32)9-4-10-29(16-24)17(2)30)14-13-27-11-7-18(8-12-27)22-20-6-5-19(25)15-21(20)33-26-22/h5-6,15,18,32H,3-4,7-14,16H2,1-2H3	BTICABKVLJBOCS-UHFFFAOYSA-N	555096	US11339151, Example 72	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 9900							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555096&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163466827	471695852							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171009	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(CCC1O)C(C)=O	InChI=1S/C24H33FN4O4/c1-3-28(24(32)20-15-29(16(2)30)11-8-21(20)31)13-12-27-9-6-17(7-10-27)23-19-5-4-18(25)14-22(19)33-26-23/h4-5,14,17,20-21,31H,3,6-13,15H2,1-2H3	OBQQHIJXDBDJLM-UHFFFAOYSA-N	555098	US11339151, Example 74	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 6700							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555098&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			163828529	471695854							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171010	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(C)CC1O	InChI=1S/C22H31FN4O3/c1-3-27(22(29)18-13-25(2)14-19(18)28)11-10-26-8-6-15(7-9-26)21-17-5-4-16(23)12-20(17)30-24-21/h4-5,12,15,18-19,28H,3,6-11,13-14H2,1-2H3	SMYXZGAHTSUBQF-UHFFFAOYSA-N	555099	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-4-hydroxy-1-methylpyrrolidine-3-carboxamide::US11339151, Example 75	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 3800							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555099&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540509	471695855							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
1171011	CCN(CCN1CCC(CC1)c1noc2cc(F)ccc12)C(=O)C1CN(C)CCC1O	InChI=1S/C23H33FN4O3/c1-3-28(23(30)19-15-26(2)9-8-20(19)29)13-12-27-10-6-16(7-11-27)22-18-5-4-17(24)14-21(18)31-25-22/h4-5,14,16,19-20,29H,3,6-13,15H2,1-2H3	ZQNZTVPOPCUPTB-UHFFFAOYSA-N	555100	N-Ethyl-N-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)piperidin-1-yl]ethyl}-4-hydroxy-1-methylpiperidine-3-carboxamide::US11339151, Example 76	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2N019Q1		aid1806552	US11339151	Fujii, Y; Sakuma, M; Aihara, Y; Besnard, J; Bell, AS	5/24/2022	8/29/2022	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=555100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=555100&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			156540519	471695856							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0